15340492_1|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:1902321||#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_2|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:1902321||#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_3|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:1902321||#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_4|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:1902321||#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_5|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_6|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_7|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_8|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_9|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_10|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_11|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_12|15340492|77|#section_info|0:0|We show that  synthesizes mmBCFAs de novo and utilizes the long-chain fatty acid elongation enzymes ELO-5 and ELO-6 to produce two mmBCFAs, C15ISO and C17ISO. |#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_13|15340492|77|#section_info|0:0|We show not only that the levels of C15ISO and C17ISO affect the expression of several genes, but also that the activities of some of these genes affect biosynthesis of mmBCFAs, suggesting a potential feedback regulation. One of the genes, lpd-1, encodes a homolog of a mammalian sterol regulatory element-binding protein (SREBP 1c). We present results suggesting that elo-5 and elo-6 may be transcriptional targets of LPD-1.|#main_body|GO:2000531|regulation of fatty acid biosynthetic process by regulation of transcription from RNA polymerase II promoter|#go_definition|NONE|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_14|15340492|77|#section_info|0:0|We show not only that the levels of C15ISO and C17ISO affect the expression of several genes, but also that the activities of some of these genes affect biosynthesis of mmBCFAs, suggesting a potential feedback regulation. One of the genes, lpd-1, encodes a homolog of a mammalian sterol regulatory element-binding protein (SREBP 1c). We present results suggesting that elo-5 and elo-6 may be transcriptional targets of LPD-1.|#main_body|GO:2000531|regulation of fatty acid biosynthetic process by regulation of transcription from RNA polymerase II promoter|#go_definition|NONE|GOA|WBGene00004735(176574)|#gene_synonym
##EndOfRet##
15340492_15|15340492|5959|#section_info|0:0| Synthesizes Branched-Chain FAs De Novo and Uses Two FA Elongation Enzymes to Produce C15ISO and C17ISO|#main_body|GO:1902321||#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_16|15340492|5959|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:1902321||#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_17|15340492|5959|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:1902321||#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_18|15340492|5959|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:1902321||#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_19|15340492|5959|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_20|15340492|5959|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_21|15340492|5959|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_22|15340492|5959|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_23|15340492|5959|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_24|15340492|5959|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_25|15340492|5959|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_26|15340492|5959|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_27|15340492|6731|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_28|15340492|6731|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_29|15340492|6731|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-6(177321)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_30|15340492|6731|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001244(177321)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_15|15340492|6731|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:1902321||#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_31|15340492|6731|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_32|15340492|6731|#section_info|0:0|Surprisingly, the RNAi treatment of the two remaining genes, elo-5 (F41H10.7) and elo-6 (F41H10.8), affected the levels of branched-chain FA.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_33|15340492|7132|#section_info|0:0|The RNAi of elo-6 significantly reduced the amount of only C17ISO, while the RNAi of elo-5 dramatically reduced quantities of both C15ISO and C17ISO (Figure 3).|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_34|15340492|7132|#section_info|0:0|The RNAi of elo-6 significantly reduced the amount of only C17ISO, while the RNAi of elo-5 dramatically reduced quantities of both C15ISO and C17ISO (Figure 3).|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_35|15340492|7132|#section_info|0:0|The RNAi of elo-6 significantly reduced the amount of only C17ISO, while the RNAi of elo-5 dramatically reduced quantities of both C15ISO and C17ISO (Figure 3).|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_36|15340492|7132|#section_info|0:0|The RNAi of elo-6 significantly reduced the amount of only C17ISO, while the RNAi of elo-5 dramatically reduced quantities of both C15ISO and C17ISO (Figure 3).|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_37|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D).|#main_body|GO:1902321||#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_38|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D).|#main_body|GO:1902321||#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_39|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D).|#main_body|GO:1902321||#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_40|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D).|#main_body|GO:1902321||#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_41|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D).|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_42|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D).|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_43|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D).|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_44|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D).|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_45|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:1902321||#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_46|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:1902321||#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_47|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:1902321||#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_48|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:1902321||#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_49|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_50|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_51|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_52|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_53|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_54|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_55|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_56|15340492|7132|#section_info|0:0|These results indicate that ELO-5 might be involved in the biosynthesis of C15ISO and possibly also C17ISO, whereas ELO-6 may function in elongating C15ISO to C17ISO (Figure 3C and 3D). To our best knowledge, these are the first enzymes that have been shown to be involved in long-chain mmBCFA biosynthesis in a nonbacterial in vivo system and the first enzymes of the long-chain FA elongation family related to mmBCFA production.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
0.64	15340492_94|15340492|13283|Results/Discussion|0:0|GC analysis of elo-5(RNAi) animals fed with  indicated that they not only accumulated bacterial C15ISO and C15anteISO but also efficiently elongated these FA species to C17ISO and C17anteISO, which are absent in  (Figure 6D and 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_88|15340492|13283|Results/Discussion|0:0|Because the addition of C15ISO did not result in elongation to C17ISO (Figure 6A), we wanted to determine whether ELO-6 was capable of extending an FA backbone in the absence of ELO-5, or whether the supplied free FA molecules could enter a different metabolic pathway, for instance, a degradation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_57|15340492|8309|#section_info|0:0|RNAi of Y39E4A.3 led to a significant decrease in C15ISO and C17ISO production (Figure 4B and 4C).|#main_body|GO:1902321||#go_definition|IMP|GOA|Y39E4A.3(176716)|#gene_synonym
##EndOfRet##
15340492_58|15340492|8309|#section_info|0:0|RNAi of Y39E4A.3 led to a significant decrease in C15ISO and C17ISO production (Figure 4B and 4C).|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00012713(176716)|#gene_synonym
##EndOfRet##
15340492_59|15340492|8309|#section_info|0:0|RNAi suppression of another predicted component of the BCKAD complex, pyruvate dehydrogenase (T05H10.6), resulted in a similar decrease in C15ISO and C17ISO (unpublished data), indicating a role for the  BCKAD protein in long-chain mmBCFA biosynthesis. |#main_body|GO:1902321||#go_definition|IMP|GOA|T05H10.6(3565996)|#gene_synonym
##EndOfRet##
15340492_60|15340492|8309|#section_info|0:0|RNAi suppression of another predicted component of the BCKAD complex, pyruvate dehydrogenase (T05H10.6), resulted in a similar decrease in C15ISO and C17ISO (unpublished data), indicating a role for the  BCKAD protein in long-chain mmBCFA biosynthesis. |#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00011510(3565996)|#gene_synonym
##EndOfRet##
15340492_61|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:1902321||#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_62|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:1902321||#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_63|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:1902321||#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_64|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:1902321||#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_65|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_66|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_67|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_68|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:0019367|fatty acid elongation, saturated fatty acid|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_69|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_70|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_71|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_72|15340492|8309|#section_info|0:0|Thus,  appears to use the same initial reactions to produce mmBCFAs as bacterial cells. In addition, the worm uses enzymes of the FA elongation family, ELO-5 and ELO-6, to complete the pathway.|#main_body|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_73|15340492|9917|#section_info|0:0|Blocking ELO-5 Function Causes Growth and Developmental Defects|#main_body|GO:0035264|multicellular organism growth|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_74|15340492|9917|#section_info|0:0|Blocking ELO-5 Function Causes Growth and Developmental Defects|#main_body|GO:0035264|multicellular organism growth|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_75|15340492|9917|#section_info|0:0|Blocking ELO-5 Function Causes Growth and Developmental Defects|#main_body|GO:0007275|multicellular organismal development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_76|15340492|9917|#section_info|0:0|Blocking ELO-5 Function Causes Growth and Developmental Defects|#main_body|GO:0007275|multicellular organismal development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_77|15340492|9981|#section_info|0:0|Worms originating from wild-type eggs laid on the elo-5(RNAi) plates displayed no obvious growth or morphological abnormality until the second day of adulthood, when they developed an egg-laying defect (Figure 5B). Eggs of the next generation hatched on time but the progeny arrested at the first of the four larval stages (L1). The small larvae maintained morphological integrity and could survive on a plate for up to 3-4 d. The arrest was only observed in progeny of parents exposed to elo-5 RNAi at the L1 stage.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.64	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_233|15340492|41812|Materials and Methods|0:0|Four days later, their progeny was removed and eggs of the next generation were left on the plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_234|15340492|41812|Materials and Methods|0:0|Hatched L1 were kept for 2 or 4 d before transferring as agar chunks to new elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_390|15340492|54465|Figures and Tables|0:0|(D-F) Images of worms derived from late larvae (L2-L4) placed on the RNAi plates.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_78|15340492|9981|#section_info|0:0|Worms originating from wild-type eggs laid on the elo-5(RNAi) plates displayed no obvious growth or morphological abnormality until the second day of adulthood, when they developed an egg-laying defect (Figure 5B). Eggs of the next generation hatched on time but the progeny arrested at the first of the four larval stages (L1). The small larvae maintained morphological integrity and could survive on a plate for up to 3-4 d. The arrest was only observed in progeny of parents exposed to elo-5 RNAi at the L1 stage.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.64	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_233|15340492|41812|Materials and Methods|0:0|Four days later, their progeny was removed and eggs of the next generation were left on the plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_234|15340492|41812|Materials and Methods|0:0|Hatched L1 were kept for 2 or 4 d before transferring as agar chunks to new elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_390|15340492|54465|Figures and Tables|0:0|(D-F) Images of worms derived from late larvae (L2-L4) placed on the RNAi plates.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_79|15340492|10729|#section_info|0:0|The development of the elo-5 RNAi phenotypes is likely due to a gradual elimination of the ELO-5-associated functions. Our data suggest that these functions are crucial for larval growth and development.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.67	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_2|15340492|77|abstract|0:0|hese mmBCFAs are essential for  growth and development, as suppression of their biosynthesis results in a growth arrest at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_80|15340492|10729|#section_info|0:0|The development of the elo-5 RNAi phenotypes is likely due to a gradual elimination of the ELO-5-associated functions. Our data suggest that these functions are crucial for larval growth and development.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.67	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_2|15340492|77|abstract|0:0|hese mmBCFAs are essential for  growth and development, as suppression of their biosynthesis results in a growth arrest at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_81|15340492|10729|#section_info|0:0|When parental animals were subjected to elo-5 RNAi at later larval stages (L2-L4), their progeny did not arrest in L1 but continued to develop into adulthood. The gonads appeared normal at the L4 and early adult stages, but after fertilization of one to ten oocytes, oogenesis became impaired.|#main_body|GO:0048477|oogenesis|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.61	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_82|15340492|10729|#section_info|0:0|When parental animals were subjected to elo-5 RNAi at later larval stages (L2-L4), their progeny did not arrest in L1 but continued to develop into adulthood. The gonads appeared normal at the L4 and early adult stages, but after fertilization of one to ten oocytes, oogenesis became impaired.|#main_body|GO:0048477|oogenesis|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.61	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_83|15340492|10729|#section_info|0:0|When parental animals were subjected to elo-5 RNAi at later larval stages (L2-L4), their progeny did not arrest in L1 but continued to develop into adulthood. An egg-laying defect became apparent and only a few progeny arose from these worms, which then arrested at L1.|#main_body|GO:0018991|oviposition|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.63	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_84|15340492|10729|#section_info|0:0|When parental animals were subjected to elo-5 RNAi at later larval stages (L2-L4), their progeny did not arrest in L1 but continued to develop into adulthood. An egg-laying defect became apparent and only a few progeny arose from these worms, which then arrested at L1.|#main_body|GO:0018991|oviposition|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.63	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_85|15340492|10729|#section_info|0:0|When parental animals were subjected to elo-5 RNAi at later larval stages (L2-L4), their progeny did not arrest in L1 but continued to develop into adulthood. An egg-laying defect became apparent and only a few progeny arose from these worms, which then arrested at L1.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.63	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_86|15340492|10729|#section_info|0:0|When parental animals were subjected to elo-5 RNAi at later larval stages (L2-L4), their progeny did not arrest in L1 but continued to develop into adulthood. An egg-laying defect became apparent and only a few progeny arose from these worms, which then arrested at L1.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.63	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_87|15340492|11753|#section_info|0:0|We also obtained a likely null mutant of the elo-5 gene, elo-5(gk208), which has a 245-bp deletion eliminating the predicted first exon (Genome Science Center, BC Cancer Research Center, Vancouver, British Columbia, Canada). This allele phenocopies the L1 arrest phenotype of the elo-5(RNAi) animals.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_88|15340492|11753|#section_info|0:0|We also obtained a likely null mutant of the elo-5 gene, elo-5(gk208), which has a 245-bp deletion eliminating the predicted first exon (Genome Science Center, BC Cancer Research Center, Vancouver, British Columbia, Canada). This allele phenocopies the L1 arrest phenotype of the elo-5(RNAi) animals.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_89|15340492|12054|#section_info|0:0|A Deficiency of C15ISO and C17ISO FAs Is Solely Responsible for the Defects Caused by elo-5(RNAi)|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_90|15340492|12054|#section_info|0:0|A Deficiency of C15ISO and C17ISO FAs Is Solely Responsible for the Defects Caused by elo-5(RNAi)|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_91|15340492|12152|#section_info|0:0|As predicted, the C17ISO and C17anteISO supplements rescued the elo-5 RNAi defects (in 52 of 60 and 58 of 60 plates, respectively). A partial rescue was observed on the plates supplemented with C15ISO and C15anteISO (23 of 38 and 20 of 28 plates, respectively).|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_92|15340492|12152|#section_info|0:0|As predicted, the C17ISO and C17anteISO supplements rescued the elo-5 RNAi defects (in 52 of 60 and 58 of 60 plates, respectively). A partial rescue was observed on the plates supplemented with C15ISO and C15anteISO (23 of 38 and 20 of 28 plates, respectively).|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_93|15340492|12152|#section_info|0:0|Corroborating results were obtained when homozygous elo-5(gk208) animals supplied with C17ISO grew normally.|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_94|15340492|12152|#section_info|0:0|Corroborating results were obtained when homozygous elo-5(gk208) animals supplied with C17ISO grew normally.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_95|15340492|12152|#section_info|0:0|Therefore, we have determined that only dietary 17-carbon mmBCFAs are competent to bypass the biochemical defect caused by loss of ELO-5 function.|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_96|15340492|12152|#section_info|0:0|Therefore, we have determined that only dietary 17-carbon mmBCFAs are competent to bypass the biochemical defect caused by loss of ELO-5 function.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_97|15340492|15019|#section_info|0:0|The essential roles of C15ISO and C17ISO were also supported through an examination of the elo-5(gk208) deletion mutant. The homozygous mutants grew without any obvious morphological defects when maintained on the plates supplemented with C17ISO or seeded with S. maltophilia. However, removal of the FA supplements or  by bleaching resulted in the same L1 arrest phenotype seen for the elo-5(RNAi) worms.|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_98|15340492|15019|#section_info|0:0|The essential roles of C15ISO and C17ISO were also supported through an examination of the elo-5(gk208) deletion mutant. The homozygous mutants grew without any obvious morphological defects when maintained on the plates supplemented with C17ISO or seeded with S. maltophilia. However, removal of the FA supplements or  by bleaching resulted in the same L1 arrest phenotype seen for the elo-5(RNAi) worms.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_99|15340492|15019|#section_info|0:0|The essential roles of C15ISO and C17ISO were also supported through an examination of the elo-5(gk208) deletion mutant. The homozygous mutants grew without any obvious morphological defects when maintained on the plates supplemented with C17ISO or seeded with S. maltophilia. However, removal of the FA supplements or  by bleaching resulted in the same L1 arrest phenotype seen for the elo-5(RNAi) worms.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_100|15340492|15019|#section_info|0:0|The essential roles of C15ISO and C17ISO were also supported through an examination of the elo-5(gk208) deletion mutant. The homozygous mutants grew without any obvious morphological defects when maintained on the plates supplemented with C17ISO or seeded with S. maltophilia. However, removal of the FA supplements or  by bleaching resulted in the same L1 arrest phenotype seen for the elo-5(RNAi) worms.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_101|15340492|15425|#section_info|0:0|L1 Arrest of the elo-5(RNAi) Animals Is Reversible and Related to the Variations in Levels of C17ISO during Development|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_102|15340492|15425|#section_info|0:0|L1 Arrest of the elo-5(RNAi) Animals Is Reversible and Related to the Variations in Levels of C17ISO during Development|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_103|15340492|15545|#section_info|0:0|We then asked if elo-5(RNAi) animals arrested at the L1 stage could be recovered by adding the 17-carbon mmBCFA supplements. Indeed, C17ISO and C17anteISO could effectively release L1 larvae from the developmental arrest; about 50% of 2-d-arrested and 1% of 4-d-old L1 were rescued to full growth and proliferation.|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.61	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_104|15340492|15545|#section_info|0:0|We then asked if elo-5(RNAi) animals arrested at the L1 stage could be recovered by adding the 17-carbon mmBCFA supplements. Indeed, C17ISO and C17anteISO could effectively release L1 larvae from the developmental arrest; about 50% of 2-d-arrested and 1% of 4-d-old L1 were rescued to full growth and proliferation.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.61	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_105|15340492|15545|#section_info|0:0|We then asked if elo-5(RNAi) animals arrested at the L1 stage could be recovered by adding the 17-carbon mmBCFA supplements. Indeed, C17ISO and C17anteISO could effectively release L1 larvae from the developmental arrest; about 50% of 2-d-arrested and 1% of 4-d-old L1 were rescued to full growth and proliferation.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.61	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_106|15340492|15545|#section_info|0:0|We then asked if elo-5(RNAi) animals arrested at the L1 stage could be recovered by adding the 17-carbon mmBCFA supplements. Indeed, C17ISO and C17anteISO could effectively release L1 larvae from the developmental arrest; about 50% of 2-d-arrested and 1% of 4-d-old L1 were rescued to full growth and proliferation.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.61	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_107|15340492|16226|#section_info|0:0|When RNAi-mediated disruption of elo-5 occurs at the L1 stage of a parent and consequently blocks C17ISO synthesis from that stage on, the eggs and L1 animals of the next generation are expected to contain a critically low concentration of C17ISO, halting further development.|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.67	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_2|15340492|77|abstract|0:0|hese mmBCFAs are essential for  growth and development, as suppression of their biosynthesis results in a growth arrest at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_108|15340492|16226|#section_info|0:0|When RNAi-mediated disruption of elo-5 occurs at the L1 stage of a parent and consequently blocks C17ISO synthesis from that stage on, the eggs and L1 animals of the next generation are expected to contain a critically low concentration of C17ISO, halting further development.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.67	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_2|15340492|77|abstract|0:0|hese mmBCFAs are essential for  growth and development, as suppression of their biosynthesis results in a growth arrest at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_109|15340492|16226|#section_info|0:0|When RNAi-mediated disruption of elo-5 occurs at the L1 stage of a parent and consequently blocks C17ISO synthesis from that stage on, the eggs and L1 animals of the next generation are expected to contain a critically low concentration of C17ISO, halting further development.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.67	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_2|15340492|77|abstract|0:0|hese mmBCFAs are essential for  growth and development, as suppression of their biosynthesis results in a growth arrest at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_110|15340492|16226|#section_info|0:0|When RNAi-mediated disruption of elo-5 occurs at the L1 stage of a parent and consequently blocks C17ISO synthesis from that stage on, the eggs and L1 animals of the next generation are expected to contain a critically low concentration of C17ISO, halting further development.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.67	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_2|15340492|77|abstract|0:0|hese mmBCFAs are essential for  growth and development, as suppression of their biosynthesis results in a growth arrest at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_111|15340492|17357|#section_info|0:0|If elo-5 RNAi is applied to the parent worms at or after the L2 larval stage, when the amount of C17ISO has already been elevated and/or the RNAi effect is less penetrant, the progeny may receive sufficient C17ISO to pass the L1 arrest stage. The resulting animals, however, become visibly unhealthy at the L4 and adult stages as mentioned earlier, suggesting that C17ISO also plays a role in late developmental stages.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.66	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_105|15340492|17777|Results/Discussion|0:0|In this model, the level of C17ISO is monitored at the first larval stage and the decision is made whether to proceed or pause in development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_215|15340492|40200|Materials and Methods|0:0|To obtain synchronized worms of various stages, a large quantity of N2 gravid adults were collected, bleached, and grown to the required stage on HT115 that had been transformed with pPD129.36 (control).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_226|15340492|41295|Materials and Methods|0:0|Subsequently, L2, L3, L4, young adults, and adults along with hatched L1 were collected as the separate samples.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_112|15340492|17357|#section_info|0:0|If elo-5 RNAi is applied to the parent worms at or after the L2 larval stage, when the amount of C17ISO has already been elevated and/or the RNAi effect is less penetrant, the progeny may receive sufficient C17ISO to pass the L1 arrest stage. The resulting animals, however, become visibly unhealthy at the L4 and adult stages as mentioned earlier, suggesting that C17ISO also plays a role in late developmental stages.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.66	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_105|15340492|17777|Results/Discussion|0:0|In this model, the level of C17ISO is monitored at the first larval stage and the decision is made whether to proceed or pause in development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_215|15340492|40200|Materials and Methods|0:0|To obtain synchronized worms of various stages, a large quantity of N2 gravid adults were collected, bleached, and grown to the required stage on HT115 that had been transformed with pPD129.36 (control).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_226|15340492|41295|Materials and Methods|0:0|Subsequently, L2, L3, L4, young adults, and adults along with hatched L1 were collected as the separate samples.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_113|15340492|20014|#section_info|0:0|In the elo-5(RNAi)-treated worms, a substantial loss of C15ISO and C17ISO is also accompanied by a change in the FA composition, most noticeably by the elevation in C18:1 n7 (see Figure 3C), a result consistent with the above observation.|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.64	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_114|15340492|20014|#section_info|0:0|In the elo-5(RNAi)-treated worms, a substantial loss of C15ISO and C17ISO is also accompanied by a change in the FA composition, most noticeably by the elevation in C18:1 n7 (see Figure 3C), a result consistent with the above observation.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.64	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_115|15340492|20014|#section_info|0:0|In the elo-5(RNAi)-treated worms, a substantial loss of C15ISO and C17ISO is also accompanied by a change in the FA composition, most noticeably by the elevation in C18:1 n7 (see Figure 3C), a result consistent with the above observation.|#main_body|GO:0055089|fatty acid homeostasis|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.64	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_116|15340492|20014|#section_info|0:0|In the elo-5(RNAi)-treated worms, a substantial loss of C15ISO and C17ISO is also accompanied by a change in the FA composition, most noticeably by the elevation in C18:1 n7 (see Figure 3C), a result consistent with the above observation.|#main_body|GO:0055089|fatty acid homeostasis|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.64	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_117|15340492|21939|#section_info|0:0|The Worm SREBP Homolog Controls Production of Branched-Chain FAs|#main_body|GO:1902322||#go_definition|NONE|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_118|15340492|21939|#section_info|0:0|There is only one protein in  that is homologous to mammalian SREBPs, Y47D3B.7 (the gene has been named lpd-1, for "lipid depleted 1") (McKay et al. 2003). |#main_body|GO:1902322||#go_definition|NONE|GOA|WBGene00004735(176574)|#gene_synonym
##EndOfRet##
15340492_117|15340492|22015|#section_info|0:0|There is only one protein in  that is homologous to mammalian SREBPs, Y47D3B.7 (the gene has been named lpd-1, for "lipid depleted 1") (McKay et al. 2003). |#main_body|GO:1902322||#go_definition|NONE|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_119|15340492|22796|#section_info|0:0|We first applied RNAi to lpd-1 and determined the FA composition of the mutant worms. As expected, the FA content of treated animals was significantly changed, but surprisingly the most reduced were the levels of C15ISO and C17ISO (Figure 9). Also significantly reduced was the amount of C18:2 n6. In contrast, the C16:0 level was elevated. These data indicate that, in addition to regulating the first steps of global FA biosynthesis through the activation of the ACC and FAS transcription, the worm SREBP homolog regulates mmBCFA elongation as well as desaturation of straight-chain FAs.|#main_body|GO:2000531|regulation of fatty acid biosynthetic process by regulation of transcription from RNA polymerase II promoter|#go_definition|NONE|GOA|lpd-1(176574)|#gene_synonym
0.72	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	15340492_126|15340492|21247|Results/Discussion|0:0|The changes in the FA composition associated with a decrease in C15ISO and C17ISO indicate that the metabolism of straight-chain FA species is responsive to the mmBCFA levels and suggest a cross regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_119|15340492|19259|Results/Discussion|0:0|An elevation in monounsaturated FA amounts in response to the decrease of branched-chain FAs, but not vice versa, was observed in  (Cropp et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_419|15340492|57869|Figures and Tables|0:0|The levels of C15ISO, C17ISO, and C16:0 are significantly altered by the RNAi treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_112|15340492|18330|Results/Discussion|0:0|We found that the amounts of C17ISO significantly correlated with only two other FA molecules: linoleic acid (C18:2 n6) and vaccenic acid (C18:1 n7) (Figure 8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_152|15340492|26813|Results/Discussion|0:0|This suggests that disruption of FAS does not selectively alter FA biosynthesis and that neither FAS protein is specific for mmBCFA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_50|15340492|5577|Introduction|0:0|Combining genetic, molecular, and biochemical analyses, we show that the worm is not only able to synthesize mmBCFAs de novo but is also absolutely dependent on these FA species for its growth and development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_87|15340492|13283|Results/Discussion|0:0|GC analysis of FA composition in elo-5(RNAi) worms grown on supplemented plates revealed that only C17ISO and C17anteISO are significantly incorporated into lipids (Figure 6A-6C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_106|15340492|17777|Results/Discussion|0:0|The analysis of GC data from staged animals has also indicated that the variation of the C17ISO level is correlated with only two other FA species, suggesting a potential compensatory and coregulatory mechanism.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_8|15340492|1777|Introduction|0:0|Among the most abundant in animal cells as well as the most studied are those of long-chain even-numbered saturated and unsaturated FAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_55|15340492|6063|Results/Discussion|0:0|To test for their possible functions in vivo, we applied RNAi to the corresponding genes, followed by an analysis of FA composition in whole animals using gas chromatography (GC).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_120|15340492|22796|#section_info|0:0|We first applied RNAi to lpd-1 and determined the FA composition of the mutant worms. As expected, the FA content of treated animals was significantly changed, but surprisingly the most reduced were the levels of C15ISO and C17ISO (Figure 9). Also significantly reduced was the amount of C18:2 n6. In contrast, the C16:0 level was elevated. These data indicate that, in addition to regulating the first steps of global FA biosynthesis through the activation of the ACC and FAS transcription, the worm SREBP homolog regulates mmBCFA elongation as well as desaturation of straight-chain FAs.|#main_body|GO:2000531|regulation of fatty acid biosynthetic process by regulation of transcription from RNA polymerase II promoter|#go_definition|NONE|GOA|WBGene00004735(176574)|#gene_synonym
0.72	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	15340492_126|15340492|21247|Results/Discussion|0:0|The changes in the FA composition associated with a decrease in C15ISO and C17ISO indicate that the metabolism of straight-chain FA species is responsive to the mmBCFA levels and suggest a cross regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_119|15340492|19259|Results/Discussion|0:0|An elevation in monounsaturated FA amounts in response to the decrease of branched-chain FAs, but not vice versa, was observed in  (Cropp et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_419|15340492|57869|Figures and Tables|0:0|The levels of C15ISO, C17ISO, and C16:0 are significantly altered by the RNAi treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_112|15340492|18330|Results/Discussion|0:0|We found that the amounts of C17ISO significantly correlated with only two other FA molecules: linoleic acid (C18:2 n6) and vaccenic acid (C18:1 n7) (Figure 8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_152|15340492|26813|Results/Discussion|0:0|This suggests that disruption of FAS does not selectively alter FA biosynthesis and that neither FAS protein is specific for mmBCFA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_50|15340492|5577|Introduction|0:0|Combining genetic, molecular, and biochemical analyses, we show that the worm is not only able to synthesize mmBCFAs de novo but is also absolutely dependent on these FA species for its growth and development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_87|15340492|13283|Results/Discussion|0:0|GC analysis of FA composition in elo-5(RNAi) worms grown on supplemented plates revealed that only C17ISO and C17anteISO are significantly incorporated into lipids (Figure 6A-6C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_106|15340492|17777|Results/Discussion|0:0|The analysis of GC data from staged animals has also indicated that the variation of the C17ISO level is correlated with only two other FA species, suggesting a potential compensatory and coregulatory mechanism.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_8|15340492|1777|Introduction|0:0|Among the most abundant in animal cells as well as the most studied are those of long-chain even-numbered saturated and unsaturated FAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_55|15340492|6063|Results/Discussion|0:0|To test for their possible functions in vivo, we applied RNAi to the corresponding genes, followed by an analysis of FA composition in whole animals using gas chromatography (GC).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_121|15340492|22796|#section_info|0:0|We first applied RNAi to lpd-1 and determined the FA composition of the mutant worms. As expected, the FA content of treated animals was significantly changed, but surprisingly the most reduced were the levels of C15ISO and C17ISO (Figure 9). Also significantly reduced was the amount of C18:2 n6. In contrast, the C16:0 level was elevated. These data indicate that, in addition to regulating the first steps of global FA biosynthesis through the activation of the ACC and FAS transcription, the worm SREBP homolog regulates mmBCFA elongation as well as desaturation of straight-chain FAs.|#main_body|GO:1902322||#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
0.72	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	15340492_126|15340492|21247|Results/Discussion|0:0|The changes in the FA composition associated with a decrease in C15ISO and C17ISO indicate that the metabolism of straight-chain FA species is responsive to the mmBCFA levels and suggest a cross regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_119|15340492|19259|Results/Discussion|0:0|An elevation in monounsaturated FA amounts in response to the decrease of branched-chain FAs, but not vice versa, was observed in  (Cropp et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_419|15340492|57869|Figures and Tables|0:0|The levels of C15ISO, C17ISO, and C16:0 are significantly altered by the RNAi treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_112|15340492|18330|Results/Discussion|0:0|We found that the amounts of C17ISO significantly correlated with only two other FA molecules: linoleic acid (C18:2 n6) and vaccenic acid (C18:1 n7) (Figure 8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_152|15340492|26813|Results/Discussion|0:0|This suggests that disruption of FAS does not selectively alter FA biosynthesis and that neither FAS protein is specific for mmBCFA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_50|15340492|5577|Introduction|0:0|Combining genetic, molecular, and biochemical analyses, we show that the worm is not only able to synthesize mmBCFAs de novo but is also absolutely dependent on these FA species for its growth and development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_87|15340492|13283|Results/Discussion|0:0|GC analysis of FA composition in elo-5(RNAi) worms grown on supplemented plates revealed that only C17ISO and C17anteISO are significantly incorporated into lipids (Figure 6A-6C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_106|15340492|17777|Results/Discussion|0:0|The analysis of GC data from staged animals has also indicated that the variation of the C17ISO level is correlated with only two other FA species, suggesting a potential compensatory and coregulatory mechanism.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_8|15340492|1777|Introduction|0:0|Among the most abundant in animal cells as well as the most studied are those of long-chain even-numbered saturated and unsaturated FAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_55|15340492|6063|Results/Discussion|0:0|To test for their possible functions in vivo, we applied RNAi to the corresponding genes, followed by an analysis of FA composition in whole animals using gas chromatography (GC).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_122|15340492|22796|#section_info|0:0|We first applied RNAi to lpd-1 and determined the FA composition of the mutant worms. As expected, the FA content of treated animals was significantly changed, but surprisingly the most reduced were the levels of C15ISO and C17ISO (Figure 9). Also significantly reduced was the amount of C18:2 n6. In contrast, the C16:0 level was elevated. These data indicate that, in addition to regulating the first steps of global FA biosynthesis through the activation of the ACC and FAS transcription, the worm SREBP homolog regulates mmBCFA elongation as well as desaturation of straight-chain FAs.|#main_body|GO:1902322||#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
0.72	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	15340492_126|15340492|21247|Results/Discussion|0:0|The changes in the FA composition associated with a decrease in C15ISO and C17ISO indicate that the metabolism of straight-chain FA species is responsive to the mmBCFA levels and suggest a cross regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_119|15340492|19259|Results/Discussion|0:0|An elevation in monounsaturated FA amounts in response to the decrease of branched-chain FAs, but not vice versa, was observed in  (Cropp et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_419|15340492|57869|Figures and Tables|0:0|The levels of C15ISO, C17ISO, and C16:0 are significantly altered by the RNAi treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_112|15340492|18330|Results/Discussion|0:0|We found that the amounts of C17ISO significantly correlated with only two other FA molecules: linoleic acid (C18:2 n6) and vaccenic acid (C18:1 n7) (Figure 8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_152|15340492|26813|Results/Discussion|0:0|This suggests that disruption of FAS does not selectively alter FA biosynthesis and that neither FAS protein is specific for mmBCFA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_50|15340492|5577|Introduction|0:0|Combining genetic, molecular, and biochemical analyses, we show that the worm is not only able to synthesize mmBCFAs de novo but is also absolutely dependent on these FA species for its growth and development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_87|15340492|13283|Results/Discussion|0:0|GC analysis of FA composition in elo-5(RNAi) worms grown on supplemented plates revealed that only C17ISO and C17anteISO are significantly incorporated into lipids (Figure 6A-6C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_106|15340492|17777|Results/Discussion|0:0|The analysis of GC data from staged animals has also indicated that the variation of the C17ISO level is correlated with only two other FA species, suggesting a potential compensatory and coregulatory mechanism.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_8|15340492|1777|Introduction|0:0|Among the most abundant in animal cells as well as the most studied are those of long-chain even-numbered saturated and unsaturated FAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_55|15340492|6063|Results/Discussion|0:0|To test for their possible functions in vivo, we applied RNAi to the corresponding genes, followed by an analysis of FA composition in whole animals using gas chromatography (GC).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_123|15340492|22796|#section_info|0:0|We first applied RNAi to lpd-1 and determined the FA composition of the mutant worms. As expected, the FA content of treated animals was significantly changed, but surprisingly the most reduced were the levels of C15ISO and C17ISO (Figure 9). Also significantly reduced was the amount of C18:2 n6. In contrast, the C16:0 level was elevated. These data indicate that, in addition to regulating the first steps of global FA biosynthesis through the activation of the ACC and FAS transcription, the worm SREBP homolog regulates mmBCFA elongation as well as desaturation of straight-chain FAs.|#main_body|GO:2001279|regulation of unsaturated fatty acid biosynthetic process|#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
0.72	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	15340492_126|15340492|21247|Results/Discussion|0:0|The changes in the FA composition associated with a decrease in C15ISO and C17ISO indicate that the metabolism of straight-chain FA species is responsive to the mmBCFA levels and suggest a cross regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_119|15340492|19259|Results/Discussion|0:0|An elevation in monounsaturated FA amounts in response to the decrease of branched-chain FAs, but not vice versa, was observed in  (Cropp et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_419|15340492|57869|Figures and Tables|0:0|The levels of C15ISO, C17ISO, and C16:0 are significantly altered by the RNAi treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_112|15340492|18330|Results/Discussion|0:0|We found that the amounts of C17ISO significantly correlated with only two other FA molecules: linoleic acid (C18:2 n6) and vaccenic acid (C18:1 n7) (Figure 8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_152|15340492|26813|Results/Discussion|0:0|This suggests that disruption of FAS does not selectively alter FA biosynthesis and that neither FAS protein is specific for mmBCFA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_50|15340492|5577|Introduction|0:0|Combining genetic, molecular, and biochemical analyses, we show that the worm is not only able to synthesize mmBCFAs de novo but is also absolutely dependent on these FA species for its growth and development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_87|15340492|13283|Results/Discussion|0:0|GC analysis of FA composition in elo-5(RNAi) worms grown on supplemented plates revealed that only C17ISO and C17anteISO are significantly incorporated into lipids (Figure 6A-6C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_106|15340492|17777|Results/Discussion|0:0|The analysis of GC data from staged animals has also indicated that the variation of the C17ISO level is correlated with only two other FA species, suggesting a potential compensatory and coregulatory mechanism.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_8|15340492|1777|Introduction|0:0|Among the most abundant in animal cells as well as the most studied are those of long-chain even-numbered saturated and unsaturated FAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_55|15340492|6063|Results/Discussion|0:0|To test for their possible functions in vivo, we applied RNAi to the corresponding genes, followed by an analysis of FA composition in whole animals using gas chromatography (GC).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_124|15340492|22796|#section_info|0:0|We first applied RNAi to lpd-1 and determined the FA composition of the mutant worms. As expected, the FA content of treated animals was significantly changed, but surprisingly the most reduced were the levels of C15ISO and C17ISO (Figure 9). Also significantly reduced was the amount of C18:2 n6. In contrast, the C16:0 level was elevated. These data indicate that, in addition to regulating the first steps of global FA biosynthesis through the activation of the ACC and FAS transcription, the worm SREBP homolog regulates mmBCFA elongation as well as desaturation of straight-chain FAs.|#main_body|GO:2001279|regulation of unsaturated fatty acid biosynthetic process|#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
0.72	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	15340492_126|15340492|21247|Results/Discussion|0:0|The changes in the FA composition associated with a decrease in C15ISO and C17ISO indicate that the metabolism of straight-chain FA species is responsive to the mmBCFA levels and suggest a cross regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_119|15340492|19259|Results/Discussion|0:0|An elevation in monounsaturated FA amounts in response to the decrease of branched-chain FAs, but not vice versa, was observed in  (Cropp et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_419|15340492|57869|Figures and Tables|0:0|The levels of C15ISO, C17ISO, and C16:0 are significantly altered by the RNAi treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_123|15340492|20661|Results/Discussion|0:0|In addition to the importance of linoleic acid as a substrate for polyunsaturated FA biosynthesis, its hydroxylated fatty acid derivative (HODEs) is known as a signaling molecule affecting chemotaxis (Kang and Vanderhoek 1998), cell proliferation (Eling and Glasgow 1994), and modulation of several enzymatic pathways (Hsi et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_112|15340492|18330|Results/Discussion|0:0|We found that the amounts of C17ISO significantly correlated with only two other FA molecules: linoleic acid (C18:2 n6) and vaccenic acid (C18:1 n7) (Figure 8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_152|15340492|26813|Results/Discussion|0:0|This suggests that disruption of FAS does not selectively alter FA biosynthesis and that neither FAS protein is specific for mmBCFA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_50|15340492|5577|Introduction|0:0|Combining genetic, molecular, and biochemical analyses, we show that the worm is not only able to synthesize mmBCFAs de novo but is also absolutely dependent on these FA species for its growth and development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_87|15340492|13283|Results/Discussion|0:0|GC analysis of FA composition in elo-5(RNAi) worms grown on supplemented plates revealed that only C17ISO and C17anteISO are significantly incorporated into lipids (Figure 6A-6C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_106|15340492|17777|Results/Discussion|0:0|The analysis of GC data from staged animals has also indicated that the variation of the C17ISO level is correlated with only two other FA species, suggesting a potential compensatory and coregulatory mechanism.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_8|15340492|1777|Introduction|0:0|Among the most abundant in animal cells as well as the most studied are those of long-chain even-numbered saturated and unsaturated FAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_55|15340492|6063|Results/Discussion|0:0|To test for their possible functions in vivo, we applied RNAi to the corresponding genes, followed by an analysis of FA composition in whole animals using gas chromatography (GC).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_125|15340492|23452|#section_info|0:0|The effect of lpd-1 RNAi feeding in our experiments was apparently less severe. The RNAi-treated animals displayed slow growth, morphological abnormalities, and egg-laying defects but no larval arrest.|#main_body|GO:0040018|positive regulation of multicellular organism growth|#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
0.62	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_126|15340492|23452|#section_info|0:0|The effect of lpd-1 RNAi feeding in our experiments was apparently less severe. The RNAi-treated animals displayed slow growth, morphological abnormalities, and egg-laying defects but no larval arrest.|#main_body|GO:0040018|positive regulation of multicellular organism growth|#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
0.62	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_127|15340492|23452|#section_info|0:0|The effect of lpd-1 RNAi feeding in our experiments was apparently less severe. The RNAi-treated animals displayed slow growth, morphological abnormalities, and egg-laying defects but no larval arrest.|#main_body|GO:0010171|body morphogenesis|#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
0.62	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_128|15340492|23452|#section_info|0:0|The effect of lpd-1 RNAi feeding in our experiments was apparently less severe. The RNAi-treated animals displayed slow growth, morphological abnormalities, and egg-laying defects but no larval arrest.|#main_body|GO:0010171|body morphogenesis|#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
0.62	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_129|15340492|23452|#section_info|0:0|The effect of lpd-1 RNAi feeding in our experiments was apparently less severe. The RNAi-treated animals displayed slow growth, morphological abnormalities, and egg-laying defects but no larval arrest.|#main_body|GO:0018991|oviposition|#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
0.62	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_130|15340492|23452|#section_info|0:0|The effect of lpd-1 RNAi feeding in our experiments was apparently less severe. The RNAi-treated animals displayed slow growth, morphological abnormalities, and egg-laying defects but no larval arrest.|#main_body|GO:0018991|oviposition|#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
0.62	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_131|15340492|23910|#section_info|0:0|LPD-1 is important for production of mmBCFAs as well as other very-long-chain FAs, whereas LPD-2 has no specificity for any particular type of FA.|#main_body|GO:1902324||#go_definition|NONE|GOA|lpd-1(176574)|#gene_synonym
0.63	15340492_152|15340492|26813|Results/Discussion|0:0|This suggests that disruption of FAS does not selectively alter FA biosynthesis and that neither FAS protein is specific for mmBCFA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_132|15340492|23910|#section_info|0:0|LPD-1 is important for production of mmBCFAs as well as other very-long-chain FAs, whereas LPD-2 has no specificity for any particular type of FA.|#main_body|GO:1902324||#go_definition|NONE|GOA|WBGene00004735(176574)|#gene_synonym
0.63	15340492_152|15340492|26813|Results/Discussion|0:0|This suggests that disruption of FAS does not selectively alter FA biosynthesis and that neither FAS protein is specific for mmBCFA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_133|15340492|23910|#section_info|0:0|LPD-1 is important for production of mmBCFAs as well as other very-long-chain FAs, whereas LPD-2 has no specificity for any particular type of FA.|#main_body|GO:0042761|very long-chain fatty acid biosynthetic process|#go_definition|NONE|GOA|lpd-1(176574)|#gene_synonym
0.63	15340492_152|15340492|26813|Results/Discussion|0:0|This suggests that disruption of FAS does not selectively alter FA biosynthesis and that neither FAS protein is specific for mmBCFA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_134|15340492|23910|#section_info|0:0|LPD-1 is important for production of mmBCFAs as well as other very-long-chain FAs, whereas LPD-2 has no specificity for any particular type of FA.|#main_body|GO:0042761|very long-chain fatty acid biosynthetic process|#go_definition|NONE|GOA|WBGene00004735(176574)|#gene_synonym
0.63	15340492_152|15340492|26813|Results/Discussion|0:0|This suggests that disruption of FAS does not selectively alter FA biosynthesis and that neither FAS protein is specific for mmBCFA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_135|15340492|25012|#section_info|0:0|The changes in FA composition observed in lpd-1(RNAi) would be consistent with downregulation of elo-5, elo-6 (decrease in mmBCFA), elo-2 (increase in C16:0) (Kniazeva et al. 2003), and Delta9- and/or Delta12-desaturase genes (decrease in C18:2 n6). |#main_body|GO:0042304|regulation of fatty acid biosynthetic process|#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
0.66	15340492_119|15340492|19259|Results/Discussion|0:0|An elevation in monounsaturated FA amounts in response to the decrease of branched-chain FAs, but not vice versa, was observed in  (Cropp et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_126|15340492|21247|Results/Discussion|0:0|The changes in the FA composition associated with a decrease in C15ISO and C17ISO indicate that the metabolism of straight-chain FA species is responsive to the mmBCFA levels and suggest a cross regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_136|15340492|25012|#section_info|0:0|The changes in FA composition observed in lpd-1(RNAi) would be consistent with downregulation of elo-5, elo-6 (decrease in mmBCFA), elo-2 (increase in C16:0) (Kniazeva et al. 2003), and Delta9- and/or Delta12-desaturase genes (decrease in C18:2 n6). |#main_body|GO:0042304|regulation of fatty acid biosynthetic process|#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
0.66	15340492_119|15340492|19259|Results/Discussion|0:0|An elevation in monounsaturated FA amounts in response to the decrease of branched-chain FAs, but not vice versa, was observed in  (Cropp et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_126|15340492|21247|Results/Discussion|0:0|The changes in the FA composition associated with a decrease in C15ISO and C17ISO indicate that the metabolism of straight-chain FA species is responsive to the mmBCFA levels and suggest a cross regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_137|15340492|26198|#section_info|0:0|In the worms maintained on the lpd-1(RNAi) plates, the expression was noticeably weakened, suggesting a downregulation of the promoter activities (Figure 11A-11D).|#main_body|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
0.66	15340492_159|15340492|29318|Results/Discussion|0:0|No obvious difference in the GFP expression driven by the lpd-1 promoter in intestinal cells was detected on the elo-5(RNAi) plates versus the control plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_138|15340492|26198|#section_info|0:0|In the worms maintained on the lpd-1(RNAi) plates, the expression was noticeably weakened, suggesting a downregulation of the promoter activities (Figure 11A-11D).|#main_body|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
0.66	15340492_159|15340492|29318|Results/Discussion|0:0|No obvious difference in the GFP expression driven by the lpd-1 promoter in intestinal cells was detected on the elo-5(RNAi) plates versus the control plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_139|15340492|26813|#section_info|0:0|To test if the disruption of FAS, a target of LPD-1 (McKay et al. 2003), could contribute to the observed decrease of C15ISO and C17ISO in lpd-1(RNAi), we analyzed FA composition in FAS(RNAi) strains.|#main_body|GO:1902324||#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
0.64	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_119|15340492|19259|Results/Discussion|0:0|An elevation in monounsaturated FA amounts in response to the decrease of branched-chain FAs, but not vice versa, was observed in  (Cropp et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_140|15340492|26813|#section_info|0:0|To test if the disruption of FAS, a target of LPD-1 (McKay et al. 2003), could contribute to the observed decrease of C15ISO and C17ISO in lpd-1(RNAi), we analyzed FA composition in FAS(RNAi) strains.|#main_body|GO:1902324||#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
0.64	15340492_56|15340492|6063|Results/Discussion|0:0|RNAi treatment of four genes:elo-3 (D2024.3), elo-4 (C40H1.4), elo-7 (F56H11.3), and elo-8 (Y47D3A.30):did not produce any notable phenotypes, whereas suppression of elo-1 (F56H11.4) and elo-2 (F11E6.5) affected the elongation of straight long-chain saturated and polyunsaturated FAs (Beaudoin et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_119|15340492|19259|Results/Discussion|0:0|An elevation in monounsaturated FA amounts in response to the decrease of branched-chain FAs, but not vice versa, was observed in  (Cropp et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_141|15340492|26813|#section_info|0:0|Consistent with a critical role for FAS in the first steps of FA biosynthesis, the RNAi-mediated disruption of F32H2.5 and F32H2.6 resulted in multiple defects and a lethal growth arrest (unpublished data).|#main_body|GO:0007275|multicellular organismal development|#go_definition|NONE|GOA|F32H2.5(172715)|#gene_synonym
##EndOfRet##
15340492_142|15340492|26813|#section_info|0:0|Consistent with a critical role for FAS in the first steps of FA biosynthesis, the RNAi-mediated disruption of F32H2.5 and F32H2.6 resulted in multiple defects and a lethal growth arrest (unpublished data).|#main_body|GO:0007275|multicellular organismal development|#go_definition|NONE|GOA|WBGene00009342(172715)|#gene_synonym
##EndOfRet##
15340492_143|15340492|26813|#section_info|0:0|Consistent with a critical role for FAS in the first steps of FA biosynthesis, the RNAi-mediated disruption of F32H2.5 and F32H2.6 resulted in multiple defects and a lethal growth arrest (unpublished data).|#main_body|GO:0007275|multicellular organismal development|#go_definition|NONE|GOA|F32H2.6(185214)|#gene_synonym
##EndOfRet##
15340492_144|15340492|26813|#section_info|0:0|Consistent with a critical role for FAS in the first steps of FA biosynthesis, the RNAi-mediated disruption of F32H2.5 and F32H2.6 resulted in multiple defects and a lethal growth arrest (unpublished data).|#main_body|GO:0007275|multicellular organismal development|#go_definition|NONE|GOA|WBGene00009343(185214)|#gene_synonym
##EndOfRet##
15340492_145|15340492|26813|#section_info|0:0|Therefore, downregulation of FAS by loss of lpd-1 cannot account for the severe deficiency of mmBCFA in lpd-1(RNAi).|#main_body|GO:1902324||#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_146|15340492|26813|#section_info|0:0|Therefore, downregulation of FAS by loss of lpd-1 cannot account for the severe deficiency of mmBCFA in lpd-1(RNAi).|#main_body|GO:1902324||#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
##EndOfRet##
15340492_147|15340492|27861|#section_info|0:0|Thus, we have shown that disruption of lpd-1 affects C15ISO and C17ISO biosynthesis.|#main_body|GO:1902322||#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_148|15340492|27861|#section_info|0:0|Thus, we have shown that disruption of lpd-1 affects C15ISO and C17ISO biosynthesis.|#main_body|GO:1902322||#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
##EndOfRet##
15340492_149|15340492|27861|#section_info|0:0|The fact that lpd-1, elo-5, and elo-6 are expressed in the same cells concurrently and that the GFP reporter analysis indicated that elo-5 and elo-6 transcription is downregulated in the absence of lpd-1 suggests that elo-5 and elo-6 are likely to be the targets of lpd-1.|#main_body|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_150|15340492|27861|#section_info|0:0|The fact that lpd-1, elo-5, and elo-6 are expressed in the same cells concurrently and that the GFP reporter analysis indicated that elo-5 and elo-6 transcription is downregulated in the absence of lpd-1 suggests that elo-5 and elo-6 are likely to be the targets of lpd-1.|#main_body|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
##EndOfRet##
15340492_151|15340492|28784|#section_info|0:0|A Reciprocal Correlation between lpd-1 Expression and mmBCFA Levels|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_152|15340492|28784|#section_info|0:0|Our microarray data (discussed below) indicated a 1.68-fold upregulation of lpd-1 in the elo-5(RNAi) animals, while no changes were detected in its levels between samples from wild-type animals at different developmental stages (see Materials and Methods).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00004735(176574)|#gene_synonym
##EndOfRet##
15340492_151|15340492|28852|#section_info|0:0|Our microarray data (discussed below) indicated a 1.68-fold upregulation of lpd-1 in the elo-5(RNAi) animals, while no changes were detected in its levels between samples from wild-type animals at different developmental stages (see Materials and Methods).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_153|15340492|29318|#section_info|0:0|This suggests that a chronic deficiency of mmBCFA in elo-5(RNAi) animals may transcriptionally stimulate LPD-1 production, at least in neuronal cells.|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_154|15340492|29318|#section_info|0:0|This suggests that a chronic deficiency of mmBCFA in elo-5(RNAi) animals may transcriptionally stimulate LPD-1 production, at least in neuronal cells.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_155|15340492|29318|#section_info|0:0|This suggests that a chronic deficiency of mmBCFA in elo-5(RNAi) animals may transcriptionally stimulate LPD-1 production, at least in neuronal cells.|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_156|15340492|29318|#section_info|0:0|This suggests that a chronic deficiency of mmBCFA in elo-5(RNAi) animals may transcriptionally stimulate LPD-1 production, at least in neuronal cells.|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00004735(176574)|#gene_synonym
##EndOfRet##
15340492_157|15340492|29318|#section_info|0:0|To examine the influence of the mmBCFA deficiency on lpd-1 expression, we grew the lpd-1Prom::GFP-containing strain on the elo-5(RNAi) and control plates to compare GFP fluorescence. In contrast to the observation for the intestinal cells, a strong induction of GFP was detected in amphid neurons of lpd-1Prom::GFP;elo-5(RNAi) animals (Figure 11E-11H).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|lpd-1(176574)|#gene_synonym
0.69	15340492_159|15340492|29318|Results/Discussion|0:0|No obvious difference in the GFP expression driven by the lpd-1 promoter in intestinal cells was detected on the elo-5(RNAi) plates versus the control plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_145|15340492|25546|Results/Discussion|0:0|In the strains carrying elo-5Prom::GFP and elo-6Prom::GFP reporter constructs, GFP fluorescence was also detected in the gut and several head neurons, including amphid neurons (Figure 10E-10H and Figure 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_173|15340492|33954|Results/Discussion|0:0|Expression of acs-1Prom::GFP was also detected in the canal-associated neurons in the head neurons and vulval cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_365|15340492|51971|Figures and Tables|0:0|The Expression of elo-5Prom::GFP and elo-6Prom::GFP Constructs in Wild-Type Worms|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_158|15340492|29318|#section_info|0:0|To examine the influence of the mmBCFA deficiency on lpd-1 expression, we grew the lpd-1Prom::GFP-containing strain on the elo-5(RNAi) and control plates to compare GFP fluorescence. In contrast to the observation for the intestinal cells, a strong induction of GFP was detected in amphid neurons of lpd-1Prom::GFP;elo-5(RNAi) animals (Figure 11E-11H).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00004735(176574)|#gene_synonym
0.69	15340492_159|15340492|29318|Results/Discussion|0:0|No obvious difference in the GFP expression driven by the lpd-1 promoter in intestinal cells was detected on the elo-5(RNAi) plates versus the control plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_145|15340492|25546|Results/Discussion|0:0|In the strains carrying elo-5Prom::GFP and elo-6Prom::GFP reporter constructs, GFP fluorescence was also detected in the gut and several head neurons, including amphid neurons (Figure 10E-10H and Figure 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_173|15340492|33954|Results/Discussion|0:0|Expression of acs-1Prom::GFP was also detected in the canal-associated neurons in the head neurons and vulval cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_365|15340492|51971|Figures and Tables|0:0|The Expression of elo-5Prom::GFP and elo-6Prom::GFP Constructs in Wild-Type Worms|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_159|15340492|30168|#section_info|0:0|Collectively, our results suggest that the relationship between lpd-1 and C15ISO/C17ISO is reciprocal; while downregulation of lpd-1 transcription results in the C17ISO deficiency, the C15ISO and C17ISO deficiency upregulates lpd-1 transcription at least in a subset of cells. Therefore, the worm SREBP homolog, LPD-1, may play an important role in mmBCFA homeostasis.|#main_body|GO:0031667|response to nutrient levels|#go_definition|NONE|GOA|lpd-1(176574)|#gene_synonym
0.62	15340492_164|15340492|30599|Results/Discussion|0:0|Regulation of mmBCFA homeostasis may involve transcription factors, metabolic enzymes, and transport and binding proteins.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_160|15340492|30168|#section_info|0:0|Collectively, our results suggest that the relationship between lpd-1 and C15ISO/C17ISO is reciprocal; while downregulation of lpd-1 transcription results in the C17ISO deficiency, the C15ISO and C17ISO deficiency upregulates lpd-1 transcription at least in a subset of cells. Therefore, the worm SREBP homolog, LPD-1, may play an important role in mmBCFA homeostasis.|#main_body|GO:0031667|response to nutrient levels|#go_definition|NONE|GOA|WBGene00004735(176574)|#gene_synonym
0.62	15340492_164|15340492|30599|Results/Discussion|0:0|Regulation of mmBCFA homeostasis may involve transcription factors, metabolic enzymes, and transport and binding proteins.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_161|15340492|30168|#section_info|0:0|Collectively, our results suggest that the relationship between lpd-1 and C15ISO/C17ISO is reciprocal; while downregulation of lpd-1 transcription results in the C17ISO deficiency, the C15ISO and C17ISO deficiency upregulates lpd-1 transcription at least in a subset of cells. Therefore, the worm SREBP homolog, LPD-1, may play an important role in mmBCFA homeostasis.|#main_body|GO:0055089|fatty acid homeostasis|#go_definition|NONE|GOA|lpd-1(176574)|#gene_synonym
0.62	15340492_164|15340492|30599|Results/Discussion|0:0|Regulation of mmBCFA homeostasis may involve transcription factors, metabolic enzymes, and transport and binding proteins.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_162|15340492|30168|#section_info|0:0|Collectively, our results suggest that the relationship between lpd-1 and C15ISO/C17ISO is reciprocal; while downregulation of lpd-1 transcription results in the C17ISO deficiency, the C15ISO and C17ISO deficiency upregulates lpd-1 transcription at least in a subset of cells. Therefore, the worm SREBP homolog, LPD-1, may play an important role in mmBCFA homeostasis.|#main_body|GO:0055089|fatty acid homeostasis|#go_definition|NONE|GOA|WBGene00004735(176574)|#gene_synonym
0.62	15340492_164|15340492|30599|Results/Discussion|0:0|Regulation of mmBCFA homeostasis may involve transcription factors, metabolic enzymes, and transport and binding proteins.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_163|15340492|30168|#section_info|0:0|Collectively, our results suggest that the relationship between lpd-1 and C15ISO/C17ISO is reciprocal; while downregulation of lpd-1 transcription results in the C17ISO deficiency, the C15ISO and C17ISO deficiency upregulates lpd-1 transcription at least in a subset of cells. Therefore, the worm SREBP homolog, LPD-1, may play an important role in mmBCFA homeostasis.|#main_body|GO:1902324||#go_definition|NONE|GOA|lpd-1(176574)|#gene_synonym
0.62	15340492_164|15340492|30599|Results/Discussion|0:0|Regulation of mmBCFA homeostasis may involve transcription factors, metabolic enzymes, and transport and binding proteins.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_164|15340492|30168|#section_info|0:0|Collectively, our results suggest that the relationship between lpd-1 and C15ISO/C17ISO is reciprocal; while downregulation of lpd-1 transcription results in the C17ISO deficiency, the C15ISO and C17ISO deficiency upregulates lpd-1 transcription at least in a subset of cells. Therefore, the worm SREBP homolog, LPD-1, may play an important role in mmBCFA homeostasis.|#main_body|GO:1902324||#go_definition|NONE|GOA|WBGene00004735(176574)|#gene_synonym
0.62	15340492_164|15340492|30599|Results/Discussion|0:0|Regulation of mmBCFA homeostasis may involve transcription factors, metabolic enzymes, and transport and binding proteins.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_165|15340492|31245|#section_info|0:0|RNAi of spt-1 strongly affects the FA composition without reducing the C15ISO or C17ISO levels (unpublished data).|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|sptl-1(173389)|#gene_synonym
##EndOfRet##
15340492_166|15340492|31245|#section_info|0:0|RNAi of spt-1 strongly affects the FA composition without reducing the C15ISO or C17ISO levels (unpublished data).|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00016020(173389)|#gene_synonym
##EndOfRet##
15340492_167|15340492|31245|#section_info|0:0|The F1 generation of spt-1(RNAi) animals developed gonadal and egg-laying defects that were similar to the phenotype of F1 animals from parents treated with elo-5(RNAi) at a late larval stage (described earlier; see Figure 5B and 5F).|#main_body|GO:0008406|gonad development|#go_definition|IMP|GOA|sptl-1(173389)|#gene_synonym
##EndOfRet##
15340492_168|15340492|31245|#section_info|0:0|The F1 generation of spt-1(RNAi) animals developed gonadal and egg-laying defects that were similar to the phenotype of F1 animals from parents treated with elo-5(RNAi) at a late larval stage (described earlier; see Figure 5B and 5F).|#main_body|GO:0008406|gonad development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_169|15340492|31245|#section_info|0:0|The F1 generation of spt-1(RNAi) animals developed gonadal and egg-laying defects that were similar to the phenotype of F1 animals from parents treated with elo-5(RNAi) at a late larval stage (described earlier; see Figure 5B and 5F).|#main_body|GO:0018991|oviposition|#go_definition|IMP|GOA|sptl-1(173389)|#gene_synonym
##EndOfRet##
15340492_170|15340492|31245|#section_info|0:0|The F1 generation of spt-1(RNAi) animals developed gonadal and egg-laying defects that were similar to the phenotype of F1 animals from parents treated with elo-5(RNAi) at a late larval stage (described earlier; see Figure 5B and 5F).|#main_body|GO:0018991|oviposition|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_171|15340492|32418|#section_info|0:0|RNAi of four of these genes (pnk-1 [C10G11.5], nhr-49 [K10C3.6], acs-1 [F46E10.1], and C27H6.2) significantly affected the FA composition (Figure 12).|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|pnk-1(172327)|#gene_synonym
0.68	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_172|15340492|32418|#section_info|0:0|RNAi of four of these genes (pnk-1 [C10G11.5], nhr-49 [K10C3.6], acs-1 [F46E10.1], and C27H6.2) significantly affected the FA composition (Figure 12).|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00004068(172327)|#gene_synonym
0.68	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_173|15340492|32418|#section_info|0:0|RNAi of four of these genes (pnk-1 [C10G11.5], nhr-49 [K10C3.6], acs-1 [F46E10.1], and C27H6.2) significantly affected the FA composition (Figure 12).|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|nhr-49(172839)|#gene_synonym
0.68	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_174|15340492|32418|#section_info|0:0|RNAi of four of these genes (pnk-1 [C10G11.5], nhr-49 [K10C3.6], acs-1 [F46E10.1], and C27H6.2) significantly affected the FA composition (Figure 12).|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00003639(172839)|#gene_synonym
0.68	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_175|15340492|32418|#section_info|0:0|RNAi of four of these genes (pnk-1 [C10G11.5], nhr-49 [K10C3.6], acs-1 [F46E10.1], and C27H6.2) significantly affected the FA composition (Figure 12).|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|acs-1(179043)|#gene_synonym
0.68	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_176|15340492|32418|#section_info|0:0|RNAi of four of these genes (pnk-1 [C10G11.5], nhr-49 [K10C3.6], acs-1 [F46E10.1], and C27H6.2) significantly affected the FA composition (Figure 12).|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00018488(179043)|#gene_synonym
0.68	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_177|15340492|32418|#section_info|0:0|RNAi of four of these genes (pnk-1 [C10G11.5], nhr-49 [K10C3.6], acs-1 [F46E10.1], and C27H6.2) significantly affected the FA composition (Figure 12).|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|C27H6.2(179388)|#gene_synonym
0.68	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_178|15340492|32418|#section_info|0:0|RNAi of four of these genes (pnk-1 [C10G11.5], nhr-49 [K10C3.6], acs-1 [F46E10.1], and C27H6.2) significantly affected the FA composition (Figure 12).|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00007784(179388)|#gene_synonym
0.68	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_179|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|pnk-1(172327)|#gene_synonym
##EndOfRet##
15340492_180|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00004068(172327)|#gene_synonym
##EndOfRet##
15340492_181|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|nhr-49(172839)|#gene_synonym
##EndOfRet##
15340492_182|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00003639(172839)|#gene_synonym
##EndOfRet##
15340492_183|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|acs-1(179043)|#gene_synonym
##EndOfRet##
15340492_184|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00018488(179043)|#gene_synonym
##EndOfRet##
15340492_185|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|C27H6.2(179388)|#gene_synonym
##EndOfRet##
15340492_186|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi).|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00007784(179388)|#gene_synonym
##EndOfRet##
15340492_187|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi).|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_188|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi).|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_189|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi). Lastly, a functional analysis shows that these three candidate genes are required for the normal level of mmBCFA production (RNAi of the genes affects mmBCFA production).|#main_body|GO:1902321||#go_definition|IMP|GOA|pnk-1(172327)|#gene_synonym
0.61	15340492_165|15340492|30599|Results/Discussion|0:0|It is reasonable to suggest that a deficiency of mmBCFA triggers a compensatory alteration in the expression of these genes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_190|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi). Lastly, a functional analysis shows that these three candidate genes are required for the normal level of mmBCFA production (RNAi of the genes affects mmBCFA production).|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00004068(172327)|#gene_synonym
0.61	15340492_165|15340492|30599|Results/Discussion|0:0|It is reasonable to suggest that a deficiency of mmBCFA triggers a compensatory alteration in the expression of these genes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_191|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi). Lastly, a functional analysis shows that these three candidate genes are required for the normal level of mmBCFA production (RNAi of the genes affects mmBCFA production).|#main_body|GO:1902321||#go_definition|IMP|GOA|nhr-49(172839)|#gene_synonym
0.61	15340492_165|15340492|30599|Results/Discussion|0:0|It is reasonable to suggest that a deficiency of mmBCFA triggers a compensatory alteration in the expression of these genes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_192|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi). Lastly, a functional analysis shows that these three candidate genes are required for the normal level of mmBCFA production (RNAi of the genes affects mmBCFA production).|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00003639(172839)|#gene_synonym
0.61	15340492_165|15340492|30599|Results/Discussion|0:0|It is reasonable to suggest that a deficiency of mmBCFA triggers a compensatory alteration in the expression of these genes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_193|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi). Lastly, a functional analysis shows that these three candidate genes are required for the normal level of mmBCFA production (RNAi of the genes affects mmBCFA production).|#main_body|GO:1902321||#go_definition|IMP|GOA|acs-1(179043)|#gene_synonym
0.61	15340492_165|15340492|30599|Results/Discussion|0:0|It is reasonable to suggest that a deficiency of mmBCFA triggers a compensatory alteration in the expression of these genes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_194|15340492|32990|#section_info|0:0|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi). Lastly, a functional analysis shows that these three candidate genes are required for the normal level of mmBCFA production (RNAi of the genes affects mmBCFA production).|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00018488(179043)|#gene_synonym
0.61	15340492_165|15340492|30599|Results/Discussion|0:0|It is reasonable to suggest that a deficiency of mmBCFA triggers a compensatory alteration in the expression of these genes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_195|15340492|32990|#section_info|0:0|The fourth candidate gene, C27H6.2, affects the level of vaccenic acid (C18:1 n7), which is related to the levels of mmBCFA (see Figure 8), suggesting cross-talk.|#main_body|GO:0033559|unsaturated fatty acid metabolic process|#go_definition|NONE|GOA|C27H6.2(179388)|#gene_synonym
0.65	15340492_112|15340492|18330|Results/Discussion|0:0|We found that the amounts of C17ISO significantly correlated with only two other FA molecules: linoleic acid (C18:2 n6) and vaccenic acid (C18:1 n7) (Figure 8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_196|15340492|32990|#section_info|0:0|The fourth candidate gene, C27H6.2, affects the level of vaccenic acid (C18:1 n7), which is related to the levels of mmBCFA (see Figure 8), suggesting cross-talk.|#main_body|GO:0033559|unsaturated fatty acid metabolic process|#go_definition|NONE|GOA|WBGene00007784(179388)|#gene_synonym
0.65	15340492_112|15340492|18330|Results/Discussion|0:0|We found that the amounts of C17ISO significantly correlated with only two other FA molecules: linoleic acid (C18:2 n6) and vaccenic acid (C18:1 n7) (Figure 8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_197|15340492|33954|#section_info|0:0|A comparison of synchronized animals grown on the control and elo-5(RNAi) plates indicated a significantly brighter fluorescence in the RNAi worms (see Figure 11I, 11J, 11L, and 11M), suggesting upregulation of acs-1and pnk-1 under C15ISO or C17ISO deficiency.|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|acs-1(179043)|#gene_synonym
0.62	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_198|15340492|33954|#section_info|0:0|A comparison of synchronized animals grown on the control and elo-5(RNAi) plates indicated a significantly brighter fluorescence in the RNAi worms (see Figure 11I, 11J, 11L, and 11M), suggesting upregulation of acs-1and pnk-1 under C15ISO or C17ISO deficiency.|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00018488(179043)|#gene_synonym
0.62	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_199|15340492|33954|#section_info|0:0|A comparison of synchronized animals grown on the control and elo-5(RNAi) plates indicated a significantly brighter fluorescence in the RNAi worms (see Figure 11I, 11J, 11L, and 11M), suggesting upregulation of acs-1and pnk-1 under C15ISO or C17ISO deficiency.|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|pnk-1(172327)|#gene_synonym
0.62	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_200|15340492|33954|#section_info|0:0|A comparison of synchronized animals grown on the control and elo-5(RNAi) plates indicated a significantly brighter fluorescence in the RNAi worms (see Figure 11I, 11J, 11L, and 11M), suggesting upregulation of acs-1and pnk-1 under C15ISO or C17ISO deficiency.|#main_body|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00004068(172327)|#gene_synonym
0.62	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_201|15340492|33954|#section_info|0:0|A comparison of synchronized animals grown on the control and elo-5(RNAi) plates indicated a significantly brighter fluorescence in the RNAi worms (see Figure 11I, 11J, 11L, and 11M), suggesting upregulation of acs-1and pnk-1 under C15ISO or C17ISO deficiency.|#main_body|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.62	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_202|15340492|33954|#section_info|0:0|A comparison of synchronized animals grown on the control and elo-5(RNAi) plates indicated a significantly brighter fluorescence in the RNAi worms (see Figure 11I, 11J, 11L, and 11M), suggesting upregulation of acs-1and pnk-1 under C15ISO or C17ISO deficiency.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.62	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_203|15340492|33954|#section_info|0:0|Moreover, pnk-1, but not acs-1, seemed to be regulated by LPD-1 because pnk-1Prom::GFP expression was significantly reduced on lpd-1(RNAi) (see Figure 11L and 11N).|#main_body|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
0.62	15340492_419|15340492|57869|Figures and Tables|0:0|The levels of C15ISO, C17ISO, and C16:0 are significantly altered by the RNAi treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_204|15340492|33954|#section_info|0:0|Moreover, pnk-1, but not acs-1, seemed to be regulated by LPD-1 because pnk-1Prom::GFP expression was significantly reduced on lpd-1(RNAi) (see Figure 11L and 11N).|#main_body|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
0.62	15340492_419|15340492|57869|Figures and Tables|0:0|The levels of C15ISO, C17ISO, and C16:0 are significantly altered by the RNAi treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_205|15340492|33954|#section_info|0:0|To detect potential feedback regulation involving acs-1 and pnk-1, we made reporter strains with GFP expression driven by acs-1 and pnk-1 promoters, acs-1Prom::GFP and pnk-1Prom::GFP, respectively. These two genes showed a higher degree of upregulation than the other candidates according to the microarray data. In addition, RNAi of these two genes resulted in a significant loss in the mmBCFA fraction.|#main_body|GO:1902321||#go_definition|IMP|GOA|pnk-1(172327)|#gene_synonym
0.63	15340492_159|15340492|29318|Results/Discussion|0:0|No obvious difference in the GFP expression driven by the lpd-1 promoter in intestinal cells was detected on the elo-5(RNAi) plates versus the control plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_145|15340492|25546|Results/Discussion|0:0|In the strains carrying elo-5Prom::GFP and elo-6Prom::GFP reporter constructs, GFP fluorescence was also detected in the gut and several head neurons, including amphid neurons (Figure 10E-10H and Figure 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_206|15340492|33954|#section_info|0:0|To detect potential feedback regulation involving acs-1 and pnk-1, we made reporter strains with GFP expression driven by acs-1 and pnk-1 promoters, acs-1Prom::GFP and pnk-1Prom::GFP, respectively. These two genes showed a higher degree of upregulation than the other candidates according to the microarray data. In addition, RNAi of these two genes resulted in a significant loss in the mmBCFA fraction.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00004068(172327)|#gene_synonym
0.63	15340492_159|15340492|29318|Results/Discussion|0:0|No obvious difference in the GFP expression driven by the lpd-1 promoter in intestinal cells was detected on the elo-5(RNAi) plates versus the control plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_145|15340492|25546|Results/Discussion|0:0|In the strains carrying elo-5Prom::GFP and elo-6Prom::GFP reporter constructs, GFP fluorescence was also detected in the gut and several head neurons, including amphid neurons (Figure 10E-10H and Figure 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_207|15340492|33954|#section_info|0:0|To detect potential feedback regulation involving acs-1 and pnk-1, we made reporter strains with GFP expression driven by acs-1 and pnk-1 promoters, acs-1Prom::GFP and pnk-1Prom::GFP, respectively. These two genes showed a higher degree of upregulation than the other candidates according to the microarray data. In addition, RNAi of these two genes resulted in a significant loss in the mmBCFA fraction.|#main_body|GO:1902321||#go_definition|IMP|GOA|acs-1(179043)|#gene_synonym
0.63	15340492_159|15340492|29318|Results/Discussion|0:0|No obvious difference in the GFP expression driven by the lpd-1 promoter in intestinal cells was detected on the elo-5(RNAi) plates versus the control plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_145|15340492|25546|Results/Discussion|0:0|In the strains carrying elo-5Prom::GFP and elo-6Prom::GFP reporter constructs, GFP fluorescence was also detected in the gut and several head neurons, including amphid neurons (Figure 10E-10H and Figure 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_208|15340492|33954|#section_info|0:0|To detect potential feedback regulation involving acs-1 and pnk-1, we made reporter strains with GFP expression driven by acs-1 and pnk-1 promoters, acs-1Prom::GFP and pnk-1Prom::GFP, respectively. These two genes showed a higher degree of upregulation than the other candidates according to the microarray data. In addition, RNAi of these two genes resulted in a significant loss in the mmBCFA fraction.|#main_body|GO:1902321||#go_definition|IMP|GOA|WBGene00018488(179043)|#gene_synonym
0.63	15340492_159|15340492|29318|Results/Discussion|0:0|No obvious difference in the GFP expression driven by the lpd-1 promoter in intestinal cells was detected on the elo-5(RNAi) plates versus the control plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_145|15340492|25546|Results/Discussion|0:0|In the strains carrying elo-5Prom::GFP and elo-6Prom::GFP reporter constructs, GFP fluorescence was also detected in the gut and several head neurons, including amphid neurons (Figure 10E-10H and Figure 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_209|15340492|35068|#section_info|0:0|Our analysis of nhr-49(RNAi) animals showed that reduction of nhr-49 activity results in upregulation of saturated FA biosynthesis that may contribute to fat accumulation.|#main_body|GO:0045717|negative regulation of fatty acid biosynthetic process|#go_definition|IMP|GOA|nhr-49(172839)|#gene_synonym
##EndOfRet##
15340492_210|15340492|35068|#section_info|0:0|Our analysis of nhr-49(RNAi) animals showed that reduction of nhr-49 activity results in upregulation of saturated FA biosynthesis that may contribute to fat accumulation.|#main_body|GO:0045717|negative regulation of fatty acid biosynthetic process|#go_definition|IMP|GOA|WBGene00003639(172839)|#gene_synonym
##EndOfRet##
15340492_211|15340492|36717|#section_info|0:0|Downregulation of the fourth candidate gene, C27H6.2, may result in a significant increase in monounsaturated FA levels (Figure 12).|#main_body|GO:0033559|unsaturated fatty acid metabolic process|#go_definition|IMP|GOA|C27H6.2(179388)|#gene_synonym
##EndOfRet##
15340492_212|15340492|36717|#section_info|0:0|Downregulation of the fourth candidate gene, C27H6.2, may result in a significant increase in monounsaturated FA levels (Figure 12).|#main_body|GO:0033559|unsaturated fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00007784(179388)|#gene_synonym
##EndOfRet##
15340492_213|15340492|36717|#section_info|0:0|This is consistent with the enlarged fraction of monounsaturated FAs observed in the elo-5(RNAi) animals (see Figure 3C).|#main_body|GO:0033559|unsaturated fatty acid metabolic process|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_214|15340492|36717|#section_info|0:0|This is consistent with the enlarged fraction of monounsaturated FAs observed in the elo-5(RNAi) animals (see Figure 3C).|#main_body|GO:0033559|unsaturated fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.62	15340492_127|15340492|21247|Results/Discussion|0:0|Interestingly, in the elo-5(RNAi) animals fed with C15ISO or C15anteISO containing bacterial supplement (S. maltophilia), the FA composition was significantly altered (see Figure 6E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_215|15340492|37588|#section_info|0:0|First, they possess a system for mmBCFA biosynthesis that includes two FA elongation enzymes, ELO-5 and ELO-6, which are regulated at least in part by the nematode homolog of SREBP-1c (lpd-1).|#main_body|GO:1902321||#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
0.62	15340492_61|15340492|7724|Results/Discussion|0:0|In bacteria, mmBCFA biosynthesis utilizes branched-chain alpha-keto-acids of leucine, isoleucine, and valine to produce mmBCFA acyl-CoA primers that substitute for acetyl-CoAs in conventional FA biosynthesis (Oku and Kaneda 1988).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_376|15340492|53204|Figures and Tables|0:0|The  BCKAD Homolog Is Involved in mmBCFA Biosynthesis|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_75|15340492|9365|Results/Discussion|0:0|Together, these data suggest that long-chain mmBCFA biosynthesis could be similar in bacteria, C. elegans, and human.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_216|15340492|37588|#section_info|0:0|First, they possess a system for mmBCFA biosynthesis that includes two FA elongation enzymes, ELO-5 and ELO-6, which are regulated at least in part by the nematode homolog of SREBP-1c (lpd-1).|#main_body|GO:1902321||#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
0.62	15340492_61|15340492|7724|Results/Discussion|0:0|In bacteria, mmBCFA biosynthesis utilizes branched-chain alpha-keto-acids of leucine, isoleucine, and valine to produce mmBCFA acyl-CoA primers that substitute for acetyl-CoAs in conventional FA biosynthesis (Oku and Kaneda 1988).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_376|15340492|53204|Figures and Tables|0:0|The  BCKAD Homolog Is Involved in mmBCFA Biosynthesis|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_75|15340492|9365|Results/Discussion|0:0|Together, these data suggest that long-chain mmBCFA biosynthesis could be similar in bacteria, C. elegans, and human.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_217|15340492|37588|#section_info|0:0|First, they possess a system for mmBCFA biosynthesis that includes two FA elongation enzymes, ELO-5 and ELO-6, which are regulated at least in part by the nematode homolog of SREBP-1c (lpd-1).|#main_body|GO:1902322||#go_definition|NONE|GOA|lpd-1(176574)|#gene_synonym
0.62	15340492_61|15340492|7724|Results/Discussion|0:0|In bacteria, mmBCFA biosynthesis utilizes branched-chain alpha-keto-acids of leucine, isoleucine, and valine to produce mmBCFA acyl-CoA primers that substitute for acetyl-CoAs in conventional FA biosynthesis (Oku and Kaneda 1988).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_376|15340492|53204|Figures and Tables|0:0|The  BCKAD Homolog Is Involved in mmBCFA Biosynthesis|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_75|15340492|9365|Results/Discussion|0:0|Together, these data suggest that long-chain mmBCFA biosynthesis could be similar in bacteria, C. elegans, and human.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_218|15340492|37588|#section_info|0:0|First, they possess a system for mmBCFA biosynthesis that includes two FA elongation enzymes, ELO-5 and ELO-6, which are regulated at least in part by the nematode homolog of SREBP-1c (lpd-1).|#main_body|GO:1902322||#go_definition|NONE|GOA|WBGene00004735(176574)|#gene_synonym
0.62	15340492_61|15340492|7724|Results/Discussion|0:0|In bacteria, mmBCFA biosynthesis utilizes branched-chain alpha-keto-acids of leucine, isoleucine, and valine to produce mmBCFA acyl-CoA primers that substitute for acetyl-CoAs in conventional FA biosynthesis (Oku and Kaneda 1988).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_376|15340492|53204|Figures and Tables|0:0|The  BCKAD Homolog Is Involved in mmBCFA Biosynthesis|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_75|15340492|9365|Results/Discussion|0:0|Together, these data suggest that long-chain mmBCFA biosynthesis could be similar in bacteria, C. elegans, and human.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_219|15340492|52654|#section_info|0:0|(C) Comparison of FA composition in three strains: wild type, elo-5(RNAi), and elo-6(RNAi). C17ISO is decreased in both RNAi strains, while C15ISO is only decreased in elo-5(RNAi).|#fig_caption|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.68	15340492_371|15340492|52420|Figures and Tables|0:0|(A and B) GC profiles showing the FA composition in the wild-type strain (Bristol N2) containing the RNAi feeding control vector and in the elo-5(RNAi) feeding strain.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_220|15340492|52654|#section_info|0:0|(C) Comparison of FA composition in three strains: wild type, elo-5(RNAi), and elo-6(RNAi). C17ISO is decreased in both RNAi strains, while C15ISO is only decreased in elo-5(RNAi).|#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.68	15340492_371|15340492|52420|Figures and Tables|0:0|(A and B) GC profiles showing the FA composition in the wild-type strain (Bristol N2) containing the RNAi feeding control vector and in the elo-5(RNAi) feeding strain.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_221|15340492|52654|#section_info|0:0|(C) Comparison of FA composition in three strains: wild type, elo-5(RNAi), and elo-6(RNAi). C17ISO is decreased in both RNAi strains, while C15ISO is only decreased in elo-5(RNAi).|#fig_caption|GO:1902321||#go_definition|IMP|GOA|elo-6(177321)|#gene_synonym
0.68	15340492_371|15340492|52420|Figures and Tables|0:0|(A and B) GC profiles showing the FA composition in the wild-type strain (Bristol N2) containing the RNAi feeding control vector and in the elo-5(RNAi) feeding strain.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_222|15340492|52654|#section_info|0:0|(C) Comparison of FA composition in three strains: wild type, elo-5(RNAi), and elo-6(RNAi). C17ISO is decreased in both RNAi strains, while C15ISO is only decreased in elo-5(RNAi).|#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00001244(177321)|#gene_synonym
0.68	15340492_371|15340492|52420|Figures and Tables|0:0|(A and B) GC profiles showing the FA composition in the wild-type strain (Bristol N2) containing the RNAi feeding control vector and in the elo-5(RNAi) feeding strain.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_232|15340492|41812|Materials and Methods|0:0|For recovering elo-5(RNAi) worms from L1 arrest, wild-type adults were placed on the elo-5(RNAi) plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_223|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:0030497|fatty acid elongation|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_224|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:0030497|fatty acid elongation|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_225|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:0030497|fatty acid elongation|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_226|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:0030497|fatty acid elongation|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_227|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_228|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_229|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_230|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_231|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:1902321||#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_232|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:1902321||#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_233|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:1902321||#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_234|15340492|52835|#section_info|0:0|(D) Suggested elongation reactions catalyzed by ELO-5 and ELO-6 in C15ISO and C17ISO biosynthesis. |#fig_caption|GO:1902321||#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_235|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_236|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_237|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_238|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:0009922|fatty acid elongase activity|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_239|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:0030497|fatty acid elongation|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_240|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:0030497|fatty acid elongation|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_241|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:0030497|fatty acid elongation|#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_242|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:0030497|fatty acid elongation|#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_243|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:1902321||#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_244|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:1902321||#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_245|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:1902321||#go_definition|NONE|GOA|elo-6(177321)|#gene_synonym
##EndOfRet##
15340492_246|15340492|52835|#section_info|0:0|Combined data presented in this figure and in the text suggest that ELO-6 acts at the elongation step from C15 to C17, whereas ELO-5 may be involved in the production of both C15ISO and C17ISO.|#fig_caption|GO:1902321||#go_definition|NONE|GOA|WBGene00001244(177321)|#gene_synonym
##EndOfRet##
15340492_247|15340492|53560|#section_info|0:0|(B) GC profiles reveal differences in the FA composition in the wild-type animals and animals treated with RNAi of E1 alpha subunit of BCKAD encoded by Y39E4A.3. |#fig_caption|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|Y39E4A.3(176716)|#gene_synonym
0.63	15340492_371|15340492|52420|Figures and Tables|0:0|(A and B) GC profiles showing the FA composition in the wild-type strain (Bristol N2) containing the RNAi feeding control vector and in the elo-5(RNAi) feeding strain.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_55|15340492|6063|Results/Discussion|0:0|To test for their possible functions in vivo, we applied RNAi to the corresponding genes, followed by an analysis of FA composition in whole animals using gas chromatography (GC).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_248|15340492|53560|#section_info|0:0|(B) GC profiles reveal differences in the FA composition in the wild-type animals and animals treated with RNAi of E1 alpha subunit of BCKAD encoded by Y39E4A.3. |#fig_caption|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00012713(176716)|#gene_synonym
0.63	15340492_371|15340492|52420|Figures and Tables|0:0|(A and B) GC profiles showing the FA composition in the wild-type strain (Bristol N2) containing the RNAi feeding control vector and in the elo-5(RNAi) feeding strain.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_55|15340492|6063|Results/Discussion|0:0|To test for their possible functions in vivo, we applied RNAi to the corresponding genes, followed by an analysis of FA composition in whole animals using gas chromatography (GC).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_249|15340492|53767|#section_info|0:0|(C) A summary of several independent preparations shows a significant decrease in both mmBCFAs in the Y39E4A.3 dsRNA-treated animals (p = 0.001 and 0.008 for C15ISO and C17ISO, respectively).|#fig_caption|GO:1902321||#go_definition|IMP|GOA|Y39E4A.3(176716)|#gene_synonym
##EndOfRet##
15340492_250|15340492|53767|#section_info|0:0|(C) A summary of several independent preparations shows a significant decrease in both mmBCFAs in the Y39E4A.3 dsRNA-treated animals (p = 0.001 and 0.008 for C15ISO and C17ISO, respectively).|#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00012713(176716)|#gene_synonym
##EndOfRet##
15340492_251|15340492|53959|#section_info|0:0|RNAi Treatment of elo-5 Causes L1 Arrest and Other Physiological Defects|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_252|15340492|53959|#section_info|0:0|RNAi Treatment of elo-5 Causes L1 Arrest and Other Physiological Defects|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_253|15340492|54180|#section_info|0:0|(B) On the second day of adulthood, these animals displayed an egg-laying defect; eggs hatched inside the worms. Arrows point to the late embryos and hatched larvae inside a worm.|#fig_caption|GO:0018991|oviposition|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.61	15340492_390|15340492|54465|Figures and Tables|0:0|(D-F) Images of worms derived from late larvae (L2-L4) placed on the RNAi plates.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_254|15340492|54180|#section_info|0:0|(B) On the second day of adulthood, these animals displayed an egg-laying defect; eggs hatched inside the worms. Arrows point to the late embryos and hatched larvae inside a worm.|#fig_caption|GO:0018991|oviposition|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.61	15340492_390|15340492|54465|Figures and Tables|0:0|(D-F) Images of worms derived from late larvae (L2-L4) placed on the RNAi plates.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_255|15340492|54360|#section_info|0:0|(C) F1 generation arrested uniformly at the first larval stage (L1), and larvae arrested for 4-5 d died.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_256|15340492|54360|#section_info|0:0|(C) F1 generation arrested uniformly at the first larval stage (L1), and larvae arrested for 4-5 d died.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_257|15340492|54547|#section_info|0:0|(D) The F1 progeny of worms developed from the treated larvae had smaller size and a scrawny morphology compared to the wild type shown in (A). |#fig_caption|GO:0040018|positive regulation of multicellular organism growth|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_258|15340492|54547|#section_info|0:0|(D) The F1 progeny of worms developed from the treated larvae had smaller size and a scrawny morphology compared to the wild type shown in (A). |#fig_caption|GO:0040018|positive regulation of multicellular organism growth|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_259|15340492|54711|#section_info|0:0|(E) These animals produced very few oocytes, some of which gave rise to embryos and L1 worms. |#fig_caption|GO:0048477|oogenesis|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_260|15340492|54711|#section_info|0:0|(E) These animals produced very few oocytes, some of which gave rise to embryos and L1 worms. |#fig_caption|GO:0048477|oogenesis|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_261|15340492|54905|#section_info|0:0|(F) The proximal part of the gonads undergoes deterioration resulting in sterility. |#fig_caption|GO:0000003|reproduction|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_262|15340492|54905|#section_info|0:0|(F) The proximal part of the gonads undergoes deterioration resulting in sterility. |#fig_caption|GO:0000003|reproduction|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_263|15340492|55390|#section_info|0:0|(A) Animals grown with C15ISO supplements were partially rescued to the wild-type phenotype; however, no accumulation of C15ISO or its elongation to C17ISO was detectable.|#fig_caption|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_264|15340492|55390|#section_info|0:0|(A) Animals grown with C15ISO supplements were partially rescued to the wild-type phenotype; however, no accumulation of C15ISO or its elongation to C17ISO was detectable.|#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_265|15340492|55562|#section_info|0:0|(B and C) Animals grown with the (B) C17ISO or (C) C17anteISO supplements were fully rescued. Peaks corresponding to C17ISO and C17anteISO are prominent.|#fig_caption|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_266|15340492|55562|#section_info|0:0|(B and C) Animals grown with the (B) C17ISO or (C) C17anteISO supplements were fully rescued. Peaks corresponding to C17ISO and C17anteISO are prominent.|#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_267|15340492|56314|#section_info|0:0|If elo-5 is suppressed in parental animals after they have begun to synthesize mmBCFA, then their eggs will have a reduced C17ISO level that is still above the critical low level, which permits these animals to grow but causes them to display gonadal defects.|#fig_caption|GO:0008406|gonad development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_268|15340492|56314|#section_info|0:0|If elo-5 is suppressed in parental animals after they have begun to synthesize mmBCFA, then their eggs will have a reduced C17ISO level that is still above the critical low level, which permits these animals to grow but causes them to display gonadal defects.|#fig_caption|GO:0008406|gonad development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_269|15340492|56314|#section_info|0:0|If elo-5 is suppressed in parental animals after they have begun to synthesize mmBCFA, then their eggs will have a reduced C17ISO level that is still above the critical low level, which permits these animals to grow but causes them to display gonadal defects.|#fig_caption|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_270|15340492|56314|#section_info|0:0|If elo-5 is suppressed in parental animals after they have begun to synthesize mmBCFA, then their eggs will have a reduced C17ISO level that is still above the critical low level, which permits these animals to grow but causes them to display gonadal defects.|#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_271|15340492|56314|#section_info|0:0|If elo-5 is suppressed in parental animals after they have begun to synthesize mmBCFA, then their eggs will have a reduced C17ISO level that is still above the critical low level, which permits these animals to grow but causes them to display gonadal defects. These worms produce a small number of progeny that is then arrested in L1.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.64	15340492_215|15340492|40200|Materials and Methods|0:0|To obtain synchronized worms of various stages, a large quantity of N2 gravid adults were collected, bleached, and grown to the required stage on HT115 that had been transformed with pPD129.36 (control).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_233|15340492|41812|Materials and Methods|0:0|Four days later, their progeny was removed and eggs of the next generation were left on the plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_105|15340492|17777|Results/Discussion|0:0|In this model, the level of C17ISO is monitored at the first larval stage and the decision is made whether to proceed or pause in development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_272|15340492|56314|#section_info|0:0|If elo-5 is suppressed in parental animals after they have begun to synthesize mmBCFA, then their eggs will have a reduced C17ISO level that is still above the critical low level, which permits these animals to grow but causes them to display gonadal defects. These worms produce a small number of progeny that is then arrested in L1.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.64	15340492_215|15340492|40200|Materials and Methods|0:0|To obtain synchronized worms of various stages, a large quantity of N2 gravid adults were collected, bleached, and grown to the required stage on HT115 that had been transformed with pPD129.36 (control).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_191|15340492|38239|Results/Discussion|0:0|However, it cannot be ruled out that the arrest is due to the failure of a metabolic or structural function that is essential for growth and development at the first larval stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_233|15340492|41812|Materials and Methods|0:0|Four days later, their progeny was removed and eggs of the next generation were left on the plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_105|15340492|17777|Results/Discussion|0:0|In this model, the level of C17ISO is monitored at the first larval stage and the decision is made whether to proceed or pause in development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_183|15340492|36115|Results/Discussion|0:0|This phenotype strikingly resembles L1 arrest of worms hatched in the absence of food (a method commonly used to obtain synchronized animals).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_189|15340492|38239|Results/Discussion|0:0|The level of C15ISO and C17ISO in eggs appears to be critical for growth and development, as animals depleted of C15ISO or C17ISO completely arrest at the L1 stage.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_273|15340492|56314|#section_info|0:0|If parental animals are treated with elo-5(RNAi) right after hatching, they are unable to initiate mmBCFA biosynthesis and the levels of C15ISO and C17ISO in their eggs are reduced to below the critical low level, resulting in L1 arrest of their progeny.|#fig_caption|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.62	15340492_233|15340492|41812|Materials and Methods|0:0|Four days later, their progeny was removed and eggs of the next generation were left on the plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_105|15340492|17777|Results/Discussion|0:0|In this model, the level of C17ISO is monitored at the first larval stage and the decision is made whether to proceed or pause in development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_274|15340492|56314|#section_info|0:0|If parental animals are treated with elo-5(RNAi) right after hatching, they are unable to initiate mmBCFA biosynthesis and the levels of C15ISO and C17ISO in their eggs are reduced to below the critical low level, resulting in L1 arrest of their progeny.|#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.62	15340492_233|15340492|41812|Materials and Methods|0:0|Four days later, their progeny was removed and eggs of the next generation were left on the plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_105|15340492|17777|Results/Discussion|0:0|In this model, the level of C17ISO is monitored at the first larval stage and the decision is made whether to proceed or pause in development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_275|15340492|56314|#section_info|0:0|If parental animals are treated with elo-5(RNAi) right after hatching, they are unable to initiate mmBCFA biosynthesis and the levels of C15ISO and C17ISO in their eggs are reduced to below the critical low level, resulting in L1 arrest of their progeny.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.62	15340492_233|15340492|41812|Materials and Methods|0:0|Four days later, their progeny was removed and eggs of the next generation were left on the plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_105|15340492|17777|Results/Discussion|0:0|In this model, the level of C17ISO is monitored at the first larval stage and the decision is made whether to proceed or pause in development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_276|15340492|56314|#section_info|0:0|If parental animals are treated with elo-5(RNAi) right after hatching, they are unable to initiate mmBCFA biosynthesis and the levels of C15ISO and C17ISO in their eggs are reduced to below the critical low level, resulting in L1 arrest of their progeny.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.62	15340492_233|15340492|41812|Materials and Methods|0:0|Four days later, their progeny was removed and eggs of the next generation were left on the plates.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_105|15340492|17777|Results/Discussion|0:0|In this model, the level of C17ISO is monitored at the first larval stage and the decision is made whether to proceed or pause in development.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_277|15340492|57791|#section_info|0:0|(A and B) The GC profiles of (A) wild-type and (B) lpd-1(RNAi)-treated worms.|#fig_caption|GO:1902322||#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_278|15340492|57791|#section_info|0:0|(A and B) The GC profiles of (A) wild-type and (B) lpd-1(RNAi)-treated worms.|#fig_caption|GO:1902322||#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
##EndOfRet##
15340492_279|15340492|59117|#section_info|0:0|(A-D) elo-5Prom::GFP expression is downregulated in the lpd-1(RNAi) background. |#fig_caption|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_280|15340492|59117|#section_info|0:0|(A-D) elo-5Prom::GFP expression is downregulated in the lpd-1(RNAi) background. |#fig_caption|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
##EndOfRet##
15340492_281|15340492|59374|#section_info|0:0|(B and D) GFP-filtered images of (B) elo-5Prom::GFP and (D) elo-5Prom::GFP in lpd-1(RNAi) animals, revealing diminished fluorescence in the gut.|#fig_caption|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
0.72	15340492_436|15340492|59218|Figures and Tables|0:0|(A and C) GFP-filtered images of (A) elo-5Prom::GFP and (C) elo-6Prom::GFP in wild-type animals, showing the characteristic bright intestinal fluorescence.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_430|15340492|58707|Figures and Tables|0:0|(E and F) Nomarski and GFP-filtered images of an animal containing elo-5Prom::GFP, revealing fluorescence in the similar amphid neuron.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_439|15340492|59648|Figures and Tables|0:0|(E and F) Nomarski and GFP images of wild-type L1 larvae containing lpd-1Prom::GFP.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_172|15340492|33954|Results/Discussion|0:0|The GFP fluorescence from acs-1Prom::GFP and pnk-1Prom::GFP was readily detectable in the gut.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_432|15340492|58863|Figures and Tables|0:0|(G and H) The intestinal and intestinal-muscle GFP expression in (G) lpd-1Prom::GFP and (H) elo-5Prom::GFP constructs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_145|15340492|25546|Results/Discussion|0:0|In the strains carrying elo-5Prom::GFP and elo-6Prom::GFP reporter constructs, GFP fluorescence was also detected in the gut and several head neurons, including amphid neurons (Figure 10E-10H and Figure 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_282|15340492|59374|#section_info|0:0|(B and D) GFP-filtered images of (B) elo-5Prom::GFP and (D) elo-5Prom::GFP in lpd-1(RNAi) animals, revealing diminished fluorescence in the gut.|#fig_caption|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
0.72	15340492_436|15340492|59218|Figures and Tables|0:0|(A and C) GFP-filtered images of (A) elo-5Prom::GFP and (C) elo-6Prom::GFP in wild-type animals, showing the characteristic bright intestinal fluorescence.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_430|15340492|58707|Figures and Tables|0:0|(E and F) Nomarski and GFP-filtered images of an animal containing elo-5Prom::GFP, revealing fluorescence in the similar amphid neuron.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_439|15340492|59648|Figures and Tables|0:0|(E and F) Nomarski and GFP images of wild-type L1 larvae containing lpd-1Prom::GFP.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	15340492_172|15340492|33954|Results/Discussion|0:0|The GFP fluorescence from acs-1Prom::GFP and pnk-1Prom::GFP was readily detectable in the gut.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_432|15340492|58863|Figures and Tables|0:0|(G and H) The intestinal and intestinal-muscle GFP expression in (G) lpd-1Prom::GFP and (H) elo-5Prom::GFP constructs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_145|15340492|25546|Results/Discussion|0:0|In the strains carrying elo-5Prom::GFP and elo-6Prom::GFP reporter constructs, GFP fluorescence was also detected in the gut and several head neurons, including amphid neurons (Figure 10E-10H and Figure 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_283|15340492|59519|#section_info|0:0|(E-H) lpd-1 expression is upregulated in neurons of the elo-5(RNAi) animals deficient for C15ISO and C17ISO. |#fig_caption|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_284|15340492|59519|#section_info|0:0|(E-H) lpd-1 expression is upregulated in neurons of the elo-5(RNAi) animals deficient for C15ISO and C17ISO. |#fig_caption|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00004735(176574)|#gene_synonym
##EndOfRet##
15340492_285|15340492|59519|#section_info|0:0|(E-H) lpd-1 expression is upregulated in neurons of the elo-5(RNAi) animals deficient for C15ISO and C17ISO. |#fig_caption|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_286|15340492|59519|#section_info|0:0|(E-H) lpd-1 expression is upregulated in neurons of the elo-5(RNAi) animals deficient for C15ISO and C17ISO. |#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_287|15340492|59732|#section_info|0:0|(G and H) Nomarski and GFP images of elo-5(RNAi)-treated animals (L1 arrested) containing lpd-1Prom::GFP, showing a visibly brighter fluorescence than that seen in (E) and (F). |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.77	15340492_439|15340492|59648|Figures and Tables|0:0|(E and F) Nomarski and GFP images of wild-type L1 larvae containing lpd-1Prom::GFP.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	15340492_430|15340492|58707|Figures and Tables|0:0|(E and F) Nomarski and GFP-filtered images of an animal containing elo-5Prom::GFP, revealing fluorescence in the similar amphid neuron.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_432|15340492|58863|Figures and Tables|0:0|(G and H) The intestinal and intestinal-muscle GFP expression in (G) lpd-1Prom::GFP and (H) elo-5Prom::GFP constructs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	15340492_436|15340492|59218|Figures and Tables|0:0|(A and C) GFP-filtered images of (A) elo-5Prom::GFP and (C) elo-6Prom::GFP in wild-type animals, showing the characteristic bright intestinal fluorescence.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_145|15340492|25546|Results/Discussion|0:0|In the strains carrying elo-5Prom::GFP and elo-6Prom::GFP reporter constructs, GFP fluorescence was also detected in the gut and several head neurons, including amphid neurons (Figure 10E-10H and Figure 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_288|15340492|59732|#section_info|0:0|(G and H) Nomarski and GFP images of elo-5(RNAi)-treated animals (L1 arrested) containing lpd-1Prom::GFP, showing a visibly brighter fluorescence than that seen in (E) and (F). |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.77	15340492_439|15340492|59648|Figures and Tables|0:0|(E and F) Nomarski and GFP images of wild-type L1 larvae containing lpd-1Prom::GFP.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	15340492_430|15340492|58707|Figures and Tables|0:0|(E and F) Nomarski and GFP-filtered images of an animal containing elo-5Prom::GFP, revealing fluorescence in the similar amphid neuron.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	15340492_432|15340492|58863|Figures and Tables|0:0|(G and H) The intestinal and intestinal-muscle GFP expression in (G) lpd-1Prom::GFP and (H) elo-5Prom::GFP constructs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	15340492_436|15340492|59218|Figures and Tables|0:0|(A and C) GFP-filtered images of (A) elo-5Prom::GFP and (C) elo-6Prom::GFP in wild-type animals, showing the characteristic bright intestinal fluorescence.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	15340492_145|15340492|25546|Results/Discussion|0:0|In the strains carrying elo-5Prom::GFP and elo-6Prom::GFP reporter constructs, GFP fluorescence was also detected in the gut and several head neurons, including amphid neurons (Figure 10E-10H and Figure 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_289|15340492|59959|#section_info|0:0|(I-K) acs-1Prom::GFP expression is upregulated in the elo-5(RNAi) animals deficient for C15ISO and C17ISO. |#fig_caption|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|acs-1(179043)|#gene_synonym
##EndOfRet##
15340492_290|15340492|59959|#section_info|0:0|(I-K) acs-1Prom::GFP expression is upregulated in the elo-5(RNAi) animals deficient for C15ISO and C17ISO. |#fig_caption|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00018488(179043)|#gene_synonym
##EndOfRet##
15340492_291|15340492|59959|#section_info|0:0|(I-K) acs-1Prom::GFP expression is upregulated in the elo-5(RNAi) animals deficient for C15ISO and C17ISO. |#fig_caption|GO:1902321||#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
15340492_292|15340492|59959|#section_info|0:0|(I-K) acs-1Prom::GFP expression is upregulated in the elo-5(RNAi) animals deficient for C15ISO and C17ISO. |#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
15340492_293|15340492|60295|#section_info|0:0|(L-N) pnk-1Prom::GFP expression is upregulated by elo-5(RNAi) but downregulated by lpd-1(RNAi). |#fig_caption|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|lpd-1(176574)|#gene_synonym
##EndOfRet##
15340492_294|15340492|60295|#section_info|0:0|(L-N) pnk-1Prom::GFP expression is upregulated by elo-5(RNAi) but downregulated by lpd-1(RNAi). |#fig_caption|GO:0045944|positive regulation of transcription from RNA polymerase II promoter|#go_definition|IMP|GOA|WBGene00004735(176574)|#gene_synonym
##EndOfRet##
15340492_295|15340492|60295|#section_info|0:0|(L-N) pnk-1Prom::GFP expression is upregulated by elo-5(RNAi) but downregulated by lpd-1(RNAi). |#fig_caption|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|pnk-1(172327)|#gene_synonym
##EndOfRet##
15340492_296|15340492|60295|#section_info|0:0|(L-N) pnk-1Prom::GFP expression is upregulated by elo-5(RNAi) but downregulated by lpd-1(RNAi). |#fig_caption|GO:0031667|response to nutrient levels|#go_definition|IEP|GOA|WBGene00004068(172327)|#gene_synonym
##EndOfRet##
15340492_297|15340492|60640|#section_info|0:0|RNAi of Four Candidate Genes with Altered Expression in elo-5(RNAi) Worms Affects the FA Composition|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|pnk-1(172327)|#gene_synonym
0.72	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_272|15340492|45887|Supporting Information|0:0|Genome-wide RNAi analysis of  fat regulatory genes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_298|15340492|60640|#section_info|0:0|RNAi of Four Candidate Genes with Altered Expression in elo-5(RNAi) Worms Affects the FA Composition|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00004068(172327)|#gene_synonym
0.72	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_272|15340492|45887|Supporting Information|0:0|Genome-wide RNAi analysis of  fat regulatory genes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_299|15340492|60640|#section_info|0:0|RNAi of Four Candidate Genes with Altered Expression in elo-5(RNAi) Worms Affects the FA Composition|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|nhr-49(172839)|#gene_synonym
0.72	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_272|15340492|45887|Supporting Information|0:0|Genome-wide RNAi analysis of  fat regulatory genes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_300|15340492|60640|#section_info|0:0|RNAi of Four Candidate Genes with Altered Expression in elo-5(RNAi) Worms Affects the FA Composition|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00003639(172839)|#gene_synonym
0.72	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_272|15340492|45887|Supporting Information|0:0|Genome-wide RNAi analysis of  fat regulatory genes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_301|15340492|60640|#section_info|0:0|RNAi of Four Candidate Genes with Altered Expression in elo-5(RNAi) Worms Affects the FA Composition|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|acs-1(179043)|#gene_synonym
0.72	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_272|15340492|45887|Supporting Information|0:0|Genome-wide RNAi analysis of  fat regulatory genes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_302|15340492|60640|#section_info|0:0|RNAi of Four Candidate Genes with Altered Expression in elo-5(RNAi) Worms Affects the FA Composition|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00018488(179043)|#gene_synonym
0.72	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_272|15340492|45887|Supporting Information|0:0|Genome-wide RNAi analysis of  fat regulatory genes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_303|15340492|60640|#section_info|0:0|RNAi of Four Candidate Genes with Altered Expression in elo-5(RNAi) Worms Affects the FA Composition|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|C27H6.2(179388)|#gene_synonym
0.72	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_272|15340492|45887|Supporting Information|0:0|Genome-wide RNAi analysis of  fat regulatory genes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_304|15340492|60640|#section_info|0:0|RNAi of Four Candidate Genes with Altered Expression in elo-5(RNAi) Worms Affects the FA Composition|#main_body|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00007784(179388)|#gene_synonym
0.72	15340492_415|15340492|57738|Figures and Tables|0:0|RNAi of the  SREBP Homolog Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	15340492_370|15340492|52346|Figures and Tables|0:0|RNAi Treatment of elo-5 and elo-6 Significantly Alters the FA Composition|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	15340492_272|15340492|45887|Supporting Information|0:0|Genome-wide RNAi analysis of  fat regulatory genes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_305|15340492|60819|#section_info|0:0|(B-D) RNAi of the three genes resulted in a decrease of the C17ISO or both C15ISO and C17ISO levels, indicated by black arrowheads. |#fig_caption|GO:1902321||#go_definition|IMP|GOA|acs-1(179043)|#gene_synonym
##EndOfRet##
15340492_306|15340492|60819|#section_info|0:0|(B-D) RNAi of the three genes resulted in a decrease of the C17ISO or both C15ISO and C17ISO levels, indicated by black arrowheads. |#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00018488(179043)|#gene_synonym
##EndOfRet##
15340492_307|15340492|60819|#section_info|0:0|(B-D) RNAi of the three genes resulted in a decrease of the C17ISO or both C15ISO and C17ISO levels, indicated by black arrowheads. |#fig_caption|GO:1902321||#go_definition|IMP|GOA|nhr-49(172839)|#gene_synonym
##EndOfRet##
15340492_308|15340492|60819|#section_info|0:0|(B-D) RNAi of the three genes resulted in a decrease of the C17ISO or both C15ISO and C17ISO levels, indicated by black arrowheads. |#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00003639(172839)|#gene_synonym
##EndOfRet##
15340492_309|15340492|60819|#section_info|0:0|(B-D) RNAi of the three genes resulted in a decrease of the C17ISO or both C15ISO and C17ISO levels, indicated by black arrowheads. |#fig_caption|GO:1902321||#go_definition|IMP|GOA|pnk-1(172327)|#gene_synonym
##EndOfRet##
15340492_310|15340492|60819|#section_info|0:0|(B-D) RNAi of the three genes resulted in a decrease of the C17ISO or both C15ISO and C17ISO levels, indicated by black arrowheads. |#fig_caption|GO:1902321||#go_definition|IMP|GOA|WBGene00004068(172327)|#gene_synonym
##EndOfRet##
15340492_311|15340492|60819|#section_info|0:0|In addition, a significant elevation in straight-chain saturated FA levels, indicated by grey arrowheads, is observed in K10C3.6(RNAi).|#fig_caption|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|nhr-49(172839)|#gene_synonym
0.61	15340492_419|15340492|57869|Figures and Tables|0:0|The levels of C15ISO, C17ISO, and C16:0 are significantly altered by the RNAi treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_312|15340492|60819|#section_info|0:0|In addition, a significant elevation in straight-chain saturated FA levels, indicated by grey arrowheads, is observed in K10C3.6(RNAi).|#fig_caption|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00003639(172839)|#gene_synonym
0.61	15340492_419|15340492|57869|Figures and Tables|0:0|The levels of C15ISO, C17ISO, and C16:0 are significantly altered by the RNAi treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_313|15340492|61087|#section_info|0:0|(E) C27H6.2(RNAi) does not cause significant changes in mmBCFA but results in an elevation of straight-chain monounsaturated FA and C18:1 n7, indicated by white arrowheads. |#fig_caption|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|C27H6.2(179388)|#gene_synonym
0.66	15340492_112|15340492|18330|Results/Discussion|0:0|We found that the amounts of C17ISO significantly correlated with only two other FA molecules: linoleic acid (C18:2 n6) and vaccenic acid (C18:1 n7) (Figure 8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_83|15340492|12152|Results/Discussion|0:0|In sharp contrast, neither saturated or mono- or polyunsaturated FA molecules (C16:0, C16:1 n7, C17:0, C18:3 n6), mmBCFAs with shorter or longer backbones (C13ISO, C18ISO, C19ISO), nor polymethyl branched phytanic acid were able to rescue or reduce defects (0 of 30 plates in each experiment).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
15340492_314|15340492|61087|#section_info|0:0|(E) C27H6.2(RNAi) does not cause significant changes in mmBCFA but results in an elevation of straight-chain monounsaturated FA and C18:1 n7, indicated by white arrowheads. |#fig_caption|GO:0006631|fatty acid metabolic process|#go_definition|IMP|GOA|WBGene00007784(179388)|#gene_synonym
0.66	15340492_112|15340492|18330|Results/Discussion|0:0|We found that the amounts of C17ISO significantly correlated with only two other FA molecules: linoleic acid (C18:2 n6) and vaccenic acid (C18:1 n7) (Figure 8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	15340492_116|15340492|19259|Results/Discussion|0:0|mmBCFAs and monounsaturated straight-chain FAs have been previously implicated in regulating membrane fluidity, which depends on the ratio of saturated FA to monounsaturated and branched-chain FA content in bacterial cells (Rilfors et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	15340492_83|15340492|12152|Results/Discussion|0:0|In sharp contrast, neither saturated or mono- or polyunsaturated FA molecules (C16:0, C16:1 n7, C17:0, C18:3 n6), mmBCFAs with shorter or longer backbones (C13ISO, C18ISO, C19ISO), nor polymethyl branched phytanic acid were able to rescue or reduce defects (0 of 30 plates in each experiment).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
